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Overview to the Thesis 
 
This thesis is divided into three sections: 
 
1) Section I:  The literature review is arranged in three parts. 
i. Part I – will explore some definitions of stress and how stress 
may effect the body 
ii. Part II – will inform on  the origins and principles of 
Osteopathy in the Cranial Field (OCF), provide information on 
the treatment related aims of OCF and critically discuss current 
research and controversy within the field 
iii. Part III – will review methodological issues involved in 
measuring stress 
 
2) Section II:  A manuscript that reports on an experimental investigation of the 
effects of an OCF session on salivary cortisol and participant self-reports of 
stress in comparison to a sham procedure. It is presented in the format 
specified for submission to the International Journal of Osteopathic Medicine.  
The following formatting exceptions have been made to the following sections 
in the interests of completeness to fulfil requirements for this thesis:  Abstract, 
Title pages to the manuscript, Keywords, Conflict of Interest, Ethical 
Considerations.  The headings used in the text of the manuscript follow APA 
formatting.  [See Appendix XII for Guide for Authors]. 
 
3) Section III:   Appendices that include ethics documentation, further 
information on outcome measures, all raw data, cortisol standard curve, 
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additional results not reported in the  manuscript for cortisol and Self-
Reoprted Stress Scores, magnitude of effect size scale, graphs for individual 
raw cortisol concentrations and effect size, and results to show comparison of 
stress task in first and second exposures. 
 
Despite over 50 years of research there is still much that is unclear about the 
mechanisms and efficacy of Osteopathy in the Cranial Field.  To date there has been a 
distinct lack of robust scientific research into the field of OCF, and in particular few 
clinical outcome measure based studies.  Controversy persists surrounding the 
physiological mechanism by which OCF may have an effect, palpable movement of 
cranial bones and whether OCF can positively affect health outcomes.  Anecdotally 
there appears to be a schism between practitioners who exclusively use OCF as a 
treatment modality, and those that completely shun OCF.  
 
The cause and effect of stress is of growing clinical and research interest and there is a 
large volume of literature surrounding this topic.  Both physical and psychological 
stress have the ability to widely affect physical health outcomes.  OCF is a treatment 
modality that targets the central nervous system with its techniques (Ward, 1997).   
There are foundational (Magoun, 1976) and present day (Peat, 2009) claims that it 
OCF can positively influence stress.   
    
Cortisol is a biomarker of stress that is secreted from the adrenal gland in response to 
stimulation from adrenocorticotrophic hormone (ACTH).  ACTH in turn is secreted 
by the pituitary gland after stimulation from corticotrophic releasing factor (CRF) 
produced by the hypothalamus in response to a stressor (Ganong, 1997).  The 
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perception of and response to the stressor is mediated centrally by the paraventricular 
nucleus in the brain and the locus coeruleus-norepinephrine system located in the 
brain stem (Feijó de Mello, Feijó de Mello, Carpenter, & Price, 2003).  Cortisol is an 
objective outcome measure that may be used to investigate claims that OCF can 
influence health outcomes modulated by the central nervous system.  The Literature 
Review explores stress, the origins of and controversy within OCF, and 
methodological considerations involved in measuring stress by salivary cortisol.  The 
following manuscript describes the present study investigating the effect of OCF on 
stress as measured by salivary cortisol.   
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Section I:  Literature Review 
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Introduction  
 
The cause and effects of excessive stress have become an international concern and 
subject of growing research interest, including a specifically-focused peer reviewed 
journal entitled “International Journal of Stress Management”.  Stress is recognised to 
have important effects on health in New Zealand society and legislation for the 
management of workplace stress has been developed and successfully prosecuted, as 
evidenced on the New Zealand Department of Labour website (2010).  A simple 
online search within New Zealand websites on “stress” returns a plethora of both 
published and unpublished material indicating that it is a topic of interest for many 
New Zealanders.   
 
Harmful or excessive stress can have a wide influence on health outcomes 
(McFarlane, 2007).  What is deemed stressful, and the response to the perceived 
stressor is acknowledged to be centrally controlled by the brain through documented 
chemical and structural changes within the brain (McEwen, 2008).   
 
This Literature Review will first operationally define stress and detail the 
physiological stress response via the hypothalamic-pituitary axis which is centrally 
controlled via chemical and structural changes within the brain (McEwen, 2008).  A 
brief synopsis on the origins, principles and treatment goals of OCF is given, and then 
a critical discussion emphasises the lack of original research with robust 
methodological designs, statistical analyses and generalisability.  The literature 
review suggests that a lack of supporting evidence for the claims on physiological 
mechanisms (Downey et al., 2006; Gard, 2009; Green, Martin, Bassett, & Kazanjin, 
1999; Sutherland & Wales, 1990), reliability of practitioner palpation in (Hanten et 
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al., 1998; Hartman & Norton, 2002; R. W. Moran & Gibbons, 2001; Sommerfeld, 
Kaider, & Klein, 2004; Wirth-Pattullo & Hayes, 1994), and health related outcome 
measures of OCF (Hanten et al., 1999; Hayden & Mullinger, 2006).  The literature 
review identifies that there is major controversy surrounding OCF and highlights the 
need for large scale, robust scientific research on health outcome measures in order 
for patients and practitioners to make well informed evidenced based treatment 
decisions.  The last part of the literature review explores the methodological issues 
involved in utilising cortisol to investigate claims that OCF can positively affect 
stress. 
 
This study will use the terms “OCF”, “cranial osteopathy” and “cranio-sacral” 
interchangeably.  CranioSacral Therapy™ is a treatment modality created as an 
offshoot to osteopathy by John E. Upledger.  OCF practitioners define themselves as 
different from CranioSacral therapists, the reasons for which this study will not 
explore.  All jargon that is specific to OCF and cranio-sacral treatment will be 
explained within the context in which it is used. 
 
 
 
 
 
 
 
Literature searches have been conducted using Boolean phrasing on PubMed, Science 
Direct, Ebsco Host, Cochrane, Mantis, and Ostmed databases, and also on the world 
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wide web.  Search terms included the key words, for example “cranial” AND 
“controversy”, “cranial” AND “suture” AND “motion”, or “stress” AND “effects” 
AND “salivary cortisol”.  Searches within searches were used to narrow result fields 
to a manageable preview number.   Related citations were also explored on papers 
that addressed the topics searched well.   The last literature search was conducted on 
3rd February 2011. 
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Part I : Stress 
Definition of Stress 
 
Definitions of stress have been evolving for over 60 years.  Hans Selye’s foundational 
work in defining stress and its relationship to disease was first published in 1936.  Ten 
years later Selye described the concept of the ‘General Adaptive Syndrome’ which 
directly relates stress to disease processes  (Selye, 1946). 
In considering the literature it appears that many authors have struggled with defining 
stress, what stressful events are, and when stress becomes harmful. 
 
Stress has been defined by Herbert, (1997) as a general term referring to any demand 
(physical or psychological) that is outside the norm and signals a disparity between 
what is optimal and what actually exists.   
 
Another definition of stress is “a specific response by the body to a stimulus, as fear 
or pain, that disturbs or interferes with the normal physiological equilibrium of an 
organism” (stress, n.d.).  This is broadened by another definition “a mentally or 
emotionally disruptive or upsetting condition occurring in response to adverse 
external influences and capable of affecting physical health, usually characterised by 
increased heart rate, a rise in blood pressure, muscular tension, irritability, and 
depression.” (American Heritage Dictionary, 2011).  It has been long acknowledged 
that stress can manifest related health impairments and can influence a person’s 
clinical presentation (Kudielka, Hellhammer, & Wüst, 2009; McFarlane, 2007).   
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It is suggested by Stefano, Fricchione & Esch, (2006) that the duration of exposure, 
and the strength of the stressors may cause stress to be a co-mediator of disease.  The 
‘General Adaptive Syndrome’ (Selye, 1946, 1978) described by Selye contains three 
stages.  The first stage is Alarm, where the fight or flight response is activated 
producing both adrenaline and cortisol.  Selye labelled the second stage Resistance, 
and describes homeostatic changes that the body makes in order to adapt to a 
persistent stressor.  Exhaustion is the third stage postulated by Selye, where the 
body’s resources are depleted whilst trying to maintain homeostasis.  It is during this 
last stage that metabolic and physiological decompensation occurs (Selye, 1946), 
accelerating pathophysiological processes (B. McEwen, 2000). 
 
A study conducted in Sweden has indicated that stressful life events are important 
predictive factors of long term sick leave (Bergh, Baigi, Månsson, Mattsson, & 
Marklund, 2007).  From a modern day perspective this kind of “stress” has been 
described as a complex process in which stressors combine to cause psychological 
distress.  Major stressors that can have a negative impact on quality of life and 
productivity have been identified as work related demands, psychological difficulties 
or difficult life events (Uegaki et al., 2010).   Taking these studies into consideration it 
might be suggested that modern day stress might be comprised of a large component 
of psychological stressors. 
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Effect of Stress on the body 
 
The stress responsive hypothalamic-adrenocorticotropic-adrenal axis is critical in 
initiating and maintaining life-sustaining adaptive reactions to internal (disease) and 
external (environmental) stressors (Keenan, Licinio, & Veldhuis, 2001). 
 
During physiological stress stimuli are transmitted centrally to the median eminence 
of the hypothalamus, where Corticotropin Releasing Factor (CRF) is secreted by the 
paraventricular nucleus of the hypothalamus, into the hypophysial portal circulation 
system.  This directly communicates the hypothalamus with the sinus of the anterior 
pituitary.  Adrenocorticotropic Hormone (ACTH) is then released from the anterior 
pituitary in the general circulation system and targets the adrenal cortex, stimulating 
the release of large amounts of cortisol (a glucocorticoid hormone) within minutes.  
This process occurs through the Hypothalamus-Pituitary-Adrenal (HPA) axis  (Singh, 
Petrides, Gold, Chrousos, & Deuster, 2006) and the locus coeruleus-noreephinephrine 
(LC-NE) system (Feijó de Mello et al., 2003).   
 
The LC-NE system is involved in extensive reciprocal innervation of regions 
throughout the central nervous system (CNS).  It plays a role in promoting an increase 
in autonomic outflow in the sympathetic nervous system (SNS) and provides 
multidirectional interaction with neural substrates involved in psychological stress 
such as the amygdala (which mediates fear, anxiety and emotional memory), the 
mesolimbic dopaminergic system (which mediates reward and pleasure) and the 
medial prefrontal cortex (which modulates complex executive behaviour and affective 
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flexibility) (Feijó de Mello et al., 2003).  As indicated in the schematic below (Figure 
1) both physical and psychological stress can cause a stress response. 
 
 
 
Figure 1:  The brain is the central organ.   
The brain is the central organ of the stress response and determines both what is 
stressful and what the stress response to those stressors will be.  Stressors may be both 
physical or psychological. 
Reprinted from McEwen (2008) by permission from Elsevier [Appendix XIII]. 
 
 
As shown in Figure (1) the brain determines both what is found stressful and what the 
stress response will be and as such individuals may vary in behavioural response to 
the same stressor.  As such the response to a stressor may vary both within and 
between individuals to the same stressor.  Allostasis is an active process by which the 
body responds to daily events to maintain homeostasis and involves accommodation 
or adaptation to a stressor; Allostatic load is considered the wear and tear that results 
from either too much stress or from inefficient management of stress (McEwen, 
2008). 
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 The brain itself also undergoes changes in response to chronic or excessive stress 
(McEwen, 2008).  McEwen suggests that it is a complex set of factors that modulates 
neuronal structure at the dendritic and neuronal cell level and that plastic structural 
changes occur in the hippocampus, the amygdala and prefrontal cortex in response to 
glucocorticoids among other hormones and neuropeptides.  It is not clear if prolonged 
excessive stress can have an irreversible effect on the brain (McEwen, 2008), but 
links are made by McEwen to major Depression and Cushing’s Disease, which the 
author states are associated with chronic elevated cortisol levels and a progressive 
reduction in the volume of the hippocampus.  The hippocampus has been identified by 
Soares & Mann (1997) as being part of a neuro-anatomic circuit that regulate 
emotion, which may suggest that chronic stress might have an irreversible effect on 
the brain, which in turn is responsible for the perception of stressors and the response 
to those stressors. 
 
Difficulties Measuring Mental Stress 
 
A systematic literature review performed by Hjortskov, Garde, Orbaek, & Hansen, 
(2004) has concluded that there is insufficient evidence for an association between 
self-reported mental stress and the cortisol response in field studies.  It is also stated 
that this could be due to a large diversity in study designs, types and measures of 
mental stress, and various salivary cortisol sampling strategies that may have 
obscured any potential relationship.    
 
Following this literature review it seems only one study has measured the relationship 
between cortisol and subjective measures of stress when both measures are taken 
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contemporaneously (Metzenthin et al. 2009).  Metzenthin et al. conclude that using a 
one-time summary measure of subjective stress contemporaneously with cortisol 
sampling may be a useful tool for evaluating workplace stress; however more studies 
are required to ascertain validity and reliability of this.  This suggests that it may be 
useful to measure the physiological response to mental stress through the objective 
cortisol response and subjective self-reports of stress simultaneously. 
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Part II : Osteopathy in the Cranial Field 
 
Clinically, stress may be treated in many ways.  One treatment modality that claims to 
have positive effects on stress is Osteopathy in the cranial field (Peat, 2009; Ward, 
1997). 
 
Origins of Osteopathy in the Cranial Field 
 
 
The health care modality known as osteopathy was first based upon a philosophy of 
medicine that focused on the unity of all the parts of the body.  It was considered that 
the musculoskeletal system was considered a key component to health and that the 
body had an intrinsic ability to heal itself (The American Osteopathic Association, 
2010).  Andrew Taylor Still founded osteopathy in the late 19th Century (Trowbridge, 
1991) in response to inadequacies that Still felt existed in western medicine (Still, 
1899).  Still began his medical career as a doctor apprenticed to his father and finally 
obtained authorisation to practice as a physician and surgeon in Macon County 
Missouri in 1893 along the American frontier (Hamonet, 2003).  During his time as an 
army physician in the American Civil War (from 1861 – 1865) Still became frustrated 
with the predominant medical philosophy of the time.  He finally lost faith in 
medicines effectiveness after the deaths of his three children from spinal meningitis, 
his wife in child birth and of another child from pneumonia despite the best efforts of 
doctors (Still, 1897).  He began openly questioning common procedures of the time, 
(such as bloodletting, blistering, rectal feeding and purging) (Tan & Zia, 2007), and 
began treating people with what he then termed ‘osteopathic manual therapy’ in 1874.   
The first school of osteopathy was opened in 1892 (Miller, 1998). 
20 
 
In 1899 William Garner Sutherland, a student of the osteopathic school, began to 
explore the bevelled articular surfaces relationship of the greater wings of the 
sphenoid and squamous portions of the temporal bones (Magoun, 1976) of the skull.  
For the next twenty years he observed dis-articulated skulls, experimented on himself 
and noted case studies (Gertrude, 2008) of the movement of the cranial bones.  
Following these observations Sutherland postulated the “primary respiratory 
mechanism” theory (Brooks, 1997) which details a physiological mechanism by 
which movement of the cranial bones might occur (Magoun, 1976).  The primary 
respiratory mechanism is postulated to involve complex interactions between the 
cerebral spinal fluid, dura mater of the brain, motility of the brain and movement at 
cranial sutures.  In 1939 Sutherland published his findings in a book called “The 
Cranial Bowl” (Sutherland, 1939), and a post-graduate teaching programme began 
under his direction in 1944 (Magoun, 1976).  This teaching programme became the 
foundations for Osteopathy in the Cranial Field (OCF).  Rollin Becker, a student of 
Sutherland’s, added to the development of OCF by attempting to further describe the 
nature of the primary respiratory mechanism (Brooks, 1997).  By the mid 20th Century 
OCF had become a widely accepted treatment choice by many osteopathic 
practitioners worldwide (Magoun, 1976). 
Literature surrounding OCF is unclear and often uses umbrella terminology such as 
“craniosacral” interchangeably with OCF; and “Cranial Rhythmic Impulse” with 
“rhythmic motions” or “primary respiratory mechanism”.  These usages are 
semantically incorrect as the term CranioSacral™ was coined and copyrighted by 
John E. Upledger to apply to a manual therapy that he developed as an offshoot of 
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OCF between 1970 and the early 1980’s (Upledger, 2005).  The term “primary 
respiratory mechanism” was coined to relate to the mechanism by which a Cranial 
Rhythmic Impulse or motion may be felt.  For the purposes of this study the usage of 
“craniosacral” will mimic the umbrella term used in the literature.  The terms “Cranial 
Rhythmic Impulse” or “rhythmic motion” will be used interchangeably, and the term 
“primary respiratory mechanism” will be used only to describe the mechanism that 
may underlie palpable cranial bone motion, as proposed by William Garner 
Sutherland. 
Principles of Osteopathy in the Cranial Field 
 
The features of the primary respiratory mechanism postulated by Sutherland include 
complex, and controversial, interactions between the fluctuation of the cerebrospinal 
fluid, the function of the reciprocal tension membrane, the motility of the neural tube, 
the articular mobility of the cranial bones and the  resulting involuntary mobility of 
the sacrum via dural connections from the central nervous system to the caudal end of 
the spinal cord (Magoun, 1966; Sutherland & Wales, 1990).  The reciprocal tension 
membrane is a phase coined by Sutherland to describe the dura mater surrounding the 
brain and its  internal extensions through the architecture of the brain (Sutherland, 
1939). 
 
In a seminal osteopathic text book, based on Sutherlands historical work (Magoun, 
1976) it is claimed that some sort of interaction between fluctuations of production 
and drainage of CSF and the inherent motility of the brain interact to produce slight 
rhythmical fluctuations of intracranial pressure.  The reciprocal tension membrane is 
then thought to restrain and translate this movement to the cranial bones.  The 
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fluctuations and motility of the CSF and central nervous system are described as 
being palpated as a slight yielding or resiliency at the cranial sutures due to movement 
of the cranial bones (Sutherland & Wales, 1990).  Magoun (1976) further describes 
these rhythmical impulses as moving from a state of “flexion” or “inspiration” to a 
state of “extension” or “expiration”.  During flexion there is a proposed lateral 
widening and an antro-posterior shortening of the cranium in which the sphenobasilar 
junction in the clivus increases its upwards convexity.  Conversely during extension a 
lateral narrowing and an antro-posterior lengthening of the cranium is claimed to 
occur in which the sphenobasilar junction in the clivus decreases its upwards 
convexity (Liem et al., 2004; Sutherland & Wales, 1990).  See Figure (2) below for an 
illustration of the sphenobasilar junction and the described movement. 
 
 
Figure 2.  Sagittal section of the skull. 
An illustration of a sagittal section of the skull, depicting proposed movement 
of the sphenobasilar junction during flexion and extension of the primary 
respiratory mechanism adapted from Gray (1918).  The Sphenoid (depicted in 
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yellow) communicates with the basiocciput portion of the Occipital bone 
(depicted in blue). 
 
It is also claimed by Liem, et al., (2004) that these “rhythmic motions” can be found 
both locally in a particular tissue, or anywhere within the entire body.  When the 
primary respiratory mechanism is claimed to be palpated, as rhythmic motions, on the 
head it is referred to as the Cranial Rhythmic Impulse (Nelson, Sergueef, & Glonek, 
2006). 
 
OCF is purported by its practitioners to use the Cranial Rhythmic Impulse to address 
many different “osteopathic lesions”.  These lesions have been described in Chaitow 
(1982) as being disturbances in the musculo-skeletal structure or function.  They are 
thought to accompany disturbances of biological mechanisms from stress or trauma 
and subsequently can affect other biological systems mediated through shared nerve 
pathways (Chaitow, 1982).  Treatment goals within OCF, aimed at osteopathic 
lesions, claim to have a positive effect on stress. 
 
Treatment Aims of Osteopathy in the Cranial Field 
 
The aim of any OCF treatment is to normalise structure and function (Ward, 1997) 
and many techniques, based around the features of the primary respiratory 
mechanism, are attempts to achieve this aim.  Treatment goals for OCF, as stated in 
Ward (1997), are known to include counteracting stress-producing factors by 
normalising function of the cerebrum, thalamus, hypothalamus and pituitary body.   In 
a section dedicated to the “counteraction of stress producing factors” under the title 
“The Aim of Treatment” Magoun (1976) surmises that cranial treatment eases 
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muscular tension and decreases afferent nerve activity.  This is claimed to relax the 
individual and calm “emotional storms” and normalise pituitary secretion for 
improved endocrine function, which in turn enhances homeostasis generally.  It is 
suggested by Magoun (1976) that this all occurs by treating the “cranial lesion”.  The 
cranial lesion is described by Magoun as having a profound influence on the central 
nervous system and the pituitary gland, leading to a “facilitated state”.  The term 
“facilitated” is used to describe an increase in nervous activity associated with a 
lowered threshold of the resting membrane potential in nerve cells, whereby 
application of a stimulus more easily provokes a response (Magoun, 1976). The 
“facilitated state” is said to cause vulnerability of the cerebral centres and systemic 
expression of many different “emotional ills”.  The aims of treatment as stated by 
Magoun (1976) and Ward (1997) are yet to be consistently validated by research on 
health outcome measures (Green et al., 1999; Hanten et al., 1999; Hayden & 
Mullinger, 2006) and both the systemic expression of stress, and the mechanism by 
which OCF may have a positive effect on stress provided by Magoun and Ward seem 
tenuous. 
 
Stress is now considered an important factor in many different disorders from chronic 
fatigue syndrome, to post-traumatic syndrome, to widespread (and often not well 
defined) musculoskeletal pain (McFarlane, 2007).  Bearing these effects of stress in 
mind, OCF practitioners throughout New Zealand regularly claim to be able to treat 
stress and stress-related conditions (Canterbury Osteopaths, 2011; Ngaio Natural 
Health Centre, 2011; Peat, 2009). 
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Controversy within the research on Osteopathy in the Cranial Field 
 
The published research into OCF falls into three main categories: theoretical 
physiological mechanisms by which OCF may operate, reliability of palpation of the 
primary respiratory mechanism and/or Cranial Rhythmic Impulse, and outcome 
measure studies on the effects of OCF on health. 
 
Theoretical physiological mechanisms for osteopathy in the cranial field. 
 
 
The physiological mechanism by which OCF was thought to have an effect on health 
originally focused on movement of cerebral spinal fluid (CSF).  In Magoun’s text 
book (1976), it is suggested that the hydrodynamic fluctuation in production of CSF 
in a contained pressure system, and its interaction (to regulate intracranial pressure) 
with arterial and venous blood, is what moves cranial bones.  This fluctuation, along 
with the inherent motility of the brain and spinal cord, is what was thought to “drive” 
the position of the cranial bones in the cranium during a two phase “flexion” and 
“extension” cycle as proposed by Liem, et al., (2004) and Sutherland & Wales, 
(1990). 
 
In 1999 a large systematic review and critical appraisal of the scientific evidence on 
craniosacral therapy (inclusive of OCF) was conducted by The British Columbia 
Office of Health Technology Assessment in order to assess whether The Worker’s 
Compensation Board of British Columbia would subsidise this treatment (Green et al., 
1999).  The review searched seven electronic medical alternative medical and 
scientific databases, libraries and appropriate professional associations – and 
evaluated a total of several hundred books, papers and articles surrounding OCF and 
26 
craniosacral therapy.  Green et al., (1999) summarised that there was evidence, from 
studies on human cadaver research, case reports, layered beam theory and intracranial 
pressure, that the adult cranial sutures do not obliterate, fuse or ossify until well into 
late life and that there is some evidence of potential movement at these sites.  Green et 
al. also claim evidence, from studies on motion of the CSF and assessment of 
craniosacral dysfunction, that a craniosacral rhythm, impulse or “primary respiration” 
independent of other body rhythms may exist (Avezaat & van Eijndhoven, 1986; 
Feinberg & Mark, 1987; Green et al., 1999).  
   
A more recent extension to traditional hypotheses for cranial motion, postulated by 
(Gard, 2009), suggests that a vascular mechanism acts to regulate the pressure inside 
the skull and CSF movement.  This regulation of pressure is claimed to physically act 
upon the bones of the cranium and spinal column thereby creating the potential for the 
“extension” and “flexion” phases previously described.  Gard proposes that the 
internal vertebral venous plexi (IVVP) (which surrounds the spinal cord) fills caudally 
to cranially forcing CSF upwards.  Once the pressure wave reaches the level of the 
skull the intracranial pressure is said to rise and the increased CSF pressure is 
purported to cause the acrachnoid granulations in the cavernous sinus to swell.  This 
swelling is thought to reduce venous flow through the sinus, redirecting blood to the 
internal jugular vein and out of the skull.  This suggested increase in CSF pressure in 
the arachnoid granulations is claimed to promote re-absorption of the CSF back into 
the venous bloodstream.  According to Gard (2009) the IVVP drains faster than it is 
filled due to the redirection of the blood flow through the internal jugular vein, and 
blood pressure drops with volume.  This in turn would allow the CSF to drain back 
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down the spinal cord and relieve the pressure on the arachnoid granulations therefore 
returning to the start of the cycle again. 
 
This new working hypothesis is supported by a review of just over 200 original 
research articles and texts on CSF formation performed over the last century 
(Orešković & Klarica, 2010).  The review was prompted by what the authors felt was 
a “considerable” amount of published experimental results and unsuccessful choroid 
plexectomies in the treatment of hydrocephaly that did not support the classic 
hypothesis of CSF formation.  The classic hypothesis of CSF formation is claimed to 
be an active formation in the choroid plexus inside brain ventricles, and drainage of 
CSF at a site outside of the ventricles (Orešković & Klarica, 2010).  Instead, after 
evaluating experimental results, Orešković & Klarica suggest that an interchange 
between interstitial fluid and CSF occurs throughout the whole of the central nervous 
system, through the blood vessels, occurs in response to hydrostatic and osmotic 
pressures.   This hypothesis has been postulated in a different field of study at around 
the same time as Gard (2009) which might lend weight to both hypotheses, however 
further research into these hypotheses is required to substantiate them. 
 
The pulsatile nature of caudal CSF movement is being increasingly postulated to be a 
phenomenon of the cardiac-related pulsations in blood volume into the cranial region 
(Bergsneider, 2001; Otáhal et al., 2007).  In a book written by Lewer-Allen, Bunt, and 
Lewer-Allen (2000), phasic patterns of brain density and ventricular shape (ie dilated 
versus non dilated ventricles) were reported within a 33 minute cycle.  It was not 
reported whether this was based upon original research, either by the author or others.  
It may be the phasic production and drainage of CSF supports the idea of a cyclical 
28 
change in CSF driving the Cranial Rhythmic Impulse.  However, these reported 
cycles have not been reproduced in any further studies (Liem et al., 2004) and do not 
match reported Cranial Rhythmic Impulse cycles cited further in this literature review. 
 
A very recent in press review of intracranial pulsatility (Wagshul, Eide, & Madsen, 
2011) concludes that literature over the past 50 years has established that the contents 
of the cranial cavity pulsates with cardiac periodicity.  Wagshul Eide & Madsen 
(2011) suggest that there may be a relationship between mean intra-cranial pressure 
and overall intra-cranial compliance.  It is also suggested that this might be important 
in the diagnosis and treatment of disease processes (Wagshul et al., 2011).  If this 
purported link between mean intra-cranial pressure and intra-cranial compliance does 
exist, and if the intra-cranial compliance does play an active role in the health and 
homeostasis of neural cells via intra-cranial fluid dynamics, it may be a way in which 
OCF can effect health outcomes.  Further research into these new hypotheses is 
required in order to draw any evidence based conclusions as to their validity. 
 
Evidence supporting the theory that an increase in intracranial pressure in healthy 
participants can cause movement at the cranial sutures is lacking.  Green et al (1999) 
surmised that available literature to date had failed to supply evidence that an increase 
in intracranial pressure could relate to movement of the cranial bones. An animal 
study measuring the effect of cranial manipulation on intracranial pressure in 
anaesthetised rabbits also challenges the idea that cranial manipulation can evoke 
intracranial pressure changes (Downey et al., 2006).  This study measured distraction 
suture separation only, not taking into account other movements such as shearing 
movements that may have occurred at the sutures, and has limitations associated with 
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generalisations to humans.  However it still provides some evidence that biological 
basis for craniosacral therapy should be continued to be explored. 
 
Reliability of the primary respiratory mechanism or cranial rhythmic 
impulse. 
 
Variations of the cycles of the Cranial Rhythmic Impulse have been recorded in many 
different rhythms, ranging from 10-14 cycles per minute (Becker, 1976; E. Lay In: 
Ward, 1997; Magoun, 1976; Ward, 1997; Wirth-Pattullo & Hayes, 1994; Woods & 
Wood, 1961) to 6-10 cycles per 10 minutes (Michael & Retzlaff, 1975).   Irrespective 
of these reported Cranial Rhythmic Impulse rates questions remain as to whether the 
movement of the cranial bones are even detectable by human palpation, or if that 
mobility has any influence on health or disease (Green et al., 1999).   
 
Several studies have investigated the reliability of craniosacral palpation (Hanten et 
al., 1998; R. W. Moran & Gibbons, 2001; Norton, 1996; Sommerfeld et al., 2004; 
Wirth-Pattullo & Hayes, 1994).  The Wirth Pattullo and Hayes (1994) study involved 
three practitioners and 12 symptomatic participants (both adult and child) (ICC = -
0.02).  They concluded that the examiners were unable to measure the cranio-sacral 
rate in a consistent manner acceptable for clinical decision making.  A small sample 
size (n =12) and large variability of readings between practitioners means that it 
remains unclear if these results are a phenomenon of the data, or if they truly 
represent inter-examiner reliability. 
 
The remaining four studies investigated both intra- and inter-examiner reliability. 
Sommerfeld et al., (2004), using 49 healthy participants, showed low inter- and intra-
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examiner  agreement and noted that under certain conditions (namely when the 
examiners were palpating “sacral primary respiratory mechanism”, and their own 
respiratory rate had increased) the examiners respiratory rate greatly influenced the 
“primary respiratory mechanism-rates” being palpated (p = 0.004 & p = 0.0001 for 
each examiner respectively).   Moran & Gibbons (2001), Hanten, et al., (1998) and 
Norton (1996) all reported fair to good intra-examiner reliability (ICC range 0.52 to 
0.73 in Moran & Gibbons study, and ICC for examiner A = 0.78 and examiner B = 
0.83 in Hanten et al. study, no statistical results stated for Norton study), and poor to 
non-existent inter-examiner reliability (ICC range -0.09 to 0.31 for Moran & Gibbons 
study, ICC between examiner A & B = 0.22 for Hanten et al. study and p<0.001 for 
the Norton study).  This suggests that each practitioner recognises and palpates a 
rhythm consistently, but that practitioners may not be palpating the same rhythm as 
each other, posing further questions about what rhythm each practitioner has 
consistently palpated.  Hanten et al., (1998) simultaneously explored the relationship 
between cardiac and respiratory rates, palpating the craniosacral rhythm using 
bivariate correlation and discovered that neither related to the participant’s cranial 
rhythm (r = 0.30 for cardiac and r = 0.42 for respiratory rates).  When comparing this 
with the Sommerfeld, et al., (2004) findings that examiner respiratory rates may 
influence “sacral primary respiratory mechanism’s” it may be that examiners’ own 
intrinsic rhythms may have more of an influence on examiners’ palpation of the 
Cranial Rhythmic Impulse than a participant’s rhythm (other than craniosacral 
rhythms).  Both Moran & Gibbons and Norton had small sample sizes (n = 11, n = 9 
respectively) suggesting that caution should once again be exercised in extrapolating 
these findings to the larger “cranial practitioner” cohort even though they do support 
the findings of Hanten et al., (1998) which is based on a larger sample size (n = 40).  
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Unfortunately Norton (1996) fails to report statistical evidence for the stated 
“significant” findings around intra-examiner reliability, which leaves the reader 
unable to critique the validity of these statements.   
 
More recent research was conducted by Nelson, et al. (2006), using 44 practitioners 
simultaneously palpating Cranial Rhythmic Impulses on 44 participants linked to 
instrumentation (laser-Doppler flowmetry which measures real-time perfusion of 
erythrocytes in tissue).  They suggest that Cranial Rhythmic Impulses are palpated by 
the practitioner in a 1:2 ratio of Cranial Rhythmic Impulse to Traube-Herring 
oscillation of arterial blood pressure fluctuations linked to respiration and vagal 
parasympathetic activity (Ganong, 1997).  This produces a rhythm slower than 
traditionally described, but which Nelson, et al., (2006) suggest is in agreement with 
other more recent studies.  The palpation ratio of 1:2 may suggest an explanation for 
differences between palpated and instrumentally recorded rates for the Cranial 
Rhythmic Impulse.  The irregularity of palpatory records, the presence of ‘osteopathic 
still points’ where Cranial Rhythmic Impulses momentarily cease, and the noted 
frequency modulation within the Cranial Rhythmic Impulse which occurred within 
their results may also contribute to the variability of sequential palpatory records 
where two practitioners track the same Cranial Rhythmic Impulse (Nelson et al., 
2006).   
 
Whilst this study utilised a larger sample size very little description is given of either 
practitioner or participants.  The results section is also severely lacking in all but the 
most basic statistical reporting (group mean with subsequent standard deviation, 
standard error and variance), presenting only graphic descriptions on Traube-Herring 
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oscillation with Cranial Rhythmic Impulse palpation that are not even referred to in 
the text.  This makes it very difficult to ascertain any construct validity, biases, 
statistical errors or even which population of practitioners or clients this study may 
most closely represent. 
 
A very recent retrospective review (Sergueef, Greer, Nelson, & Glonek, 2010), from a 
population of 734 healthy participants (made up of post-graduate and under-graduate 
students of osteopathy with varying levels of experience in OCF) and 734 examiners 
(each participant was both participant and examiner), has attempted to provide a 
normative rate and range for the Cranial Rhythmic Impulse.  They report that the 
more experienced the OCF practitioner the lower the variance between Cranial 
Rhythmic Impulse rate and the lower the rate in cycles per minute (cpm) (first year in 
a two year OCF course of study: mean Cranial Rhythmic Impulse = 7.4 cpm, SD = 
4.7;  completed two year course on OCF: mean Cranial Rhythmic Impulse = 6.5 cpm, 
SD = 4.1; three to 25 years of experience as an OCF practitioner attending a 
postgraduate OCF course: mean Cranial Rhythmic Impulse = 4.7 cpm, SD = 2.6; 
difference between each grouped level of experience by way of one-way ANOVA p < 
0.001).  This study suggests that the accepted range of palpated Cranial Rhythmic 
Impulse should be 2 to 7 cycles per minute, which is in agreement with the rates 
previously recorded by the Nelson et al., (2006) study.  The large sample size, well 
described methodology, comprehensive statistical analysis and the attempted blinding 
of practitioners to the length of measurement and other practitioners recorded Cranial 
Rhythmic Impulse rates make this study the most robust to date.  However all 
participants are students and practitioners of OCF, therefore naivety to OCF has not 
been controlled.  Within Cranial Rhythmic Impulse reliability trials the OCF 
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practitioner cannot be blinded to the already known expected Cranial Rhythmic 
Impulse rates: in this study the participants might also know what expected Cranial 
Rhythmic Impulses would be.  Whilst there is evidence that each grouped level of 
experience is distinct from one another (difference between grouped levels of 
experience: p > 0.001) there is no control given to expectation bias from practitioner 
experience of Cranial Rhythmic Impulse rates influencing the palpated experimental 
rate.  It is therefore difficult to ascertain if the difference between grouped levels of 
experience is due to an increased palpation skill, or previous knowledge and 
experience influencing the palpated rate.  Participant pairs were asked to swap roles at 
the end of the first run of the experimental protocol.  No statistical analysis was 
provided on the differences between participants that were participant 
first/practitioner second and practitioner first/participant second.  Participants that 
were practitioners second could no longer have been blinded to measurement length, 
and this may have impacted on the Cranial Rhythmic Impulse rates recorded.  
Generalisability of this study to the general public is limited as the participants were 
sampled from an entirely professional population.   
 
Literature on this subject is mostly highly variable and lacking in consistency (many 
differing Cranial Rhythmic Impulse rates are recorded and intra- and inter-examiner 
reliability studies often do not agree), and of poor methodological quality (small 
sample sizes, statistical analysis and methodology incomplete or un-reported).  Green 
et al., (1999) also provided a similar assessment of the literature up until 1999.  The 
only large study conducted since then (Sergueef et al., 2010) is of limited value due to 
its lack of generalisability to the public. 
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Clinical outcome measure studies on effects of osteopathy in the 
cranial field. 
 
 
To date there are very few investigations into the efficacy of OCF, and only two 
randomised controlled trials (Hanten et al., 1999; Hayden & Mullinger, 2006).  The 
Hanten et al. trial was a US based study investigating the immediate effects of the 
CV-4 technique of OCF (by comparing a 10 minute treatment with a resting position 
and lying still for 10 minutes) concluding that this was an effective treatment for 
tension type headaches (Hanten et al., 1999).  The CV-4 technique in OCF is claimed 
to affect the fourth ventricle within the brain, where classical theories on CSF 
production suggest most of the CSF is produced.  However, as highlighted in a critical 
appraisal of the Hanten et al., study by Saunders (2001) the US trial is flawed in many 
methodological respects (Saunders, 2001).  No mention of investigator blinding is 
made.  Also it is not clear whether participants were aware of which intervention they 
were receiving or if they were naïve to OCF.  Participants may therefore have 
responded according to their perception of what was expected by investigators or to 
their own expectations.  Sampling details in the report are scant.  It is not clear from 
where the study population is drawn from and no participant information apart from 
age were provided.  This means that the reader is unable to determine if what 
selection bias has occurred, for example if all participants selected were people 
already convinced of the benefits of similar treatments, or what population groups 
these results might be generalisable to.    
 
The second randomised controlled trial, containing 28 participants was based in the 
UK, and investigated the effects of cranial osteopathic treatment on the pattern of 
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increased crying, irritability and disturbed sleep associated with infantile colic, as 
reported by the parents (Hayden & Mullinger, 2006).   The authors concluded that 
preliminary findings suggest that cranial osteopathic treatment can benefit infants 
with colic (p < 0.001 reduction in crying; p < 0.002 increase in sleeping).  A good 
explanation of participant sampling is given.  Inclusion criteria is well described and 
would have selected appropriate participants.  The methodological design was robust, 
utilising a control group controlling for placebo effect and the effect of parental 
counselling given by the osteopathic practitioner during a normal session.  Statistical 
analysis was simplistic, showing mean comparisons by way of Student t-tests.  This 
may have introduced some statistical error as the study does not describe clearly how 
many Student t-tests were used, and the effect being measured for might have been 
inflated if numerous effects were being tested for (Hopkins, 2000).  No mention is 
made whether confidence intervals were adjusted within the independent t-tests to 
allow for an inflation of the overall Type I error rate (Hopkins, 2000).  
 
A more recent preliminary investigation conducted by Milnes & Moran (2007) into 
physiological outcome measures following treatment with the CV-4 technique failed 
to support commonly theorised autonomic effects (changes in galvanic skin response, 
heart rate variability and respiration rate) of the CV-4.  Small sample size, possible 
pre-conceptions of participants, the use of only one cranial practitioner and emerging 
evidence that galvanic skin response has little correlation with other parameters that 
represent sympathetic activity all limit the clinical generalisability of this study.  
Further research should address these issues by increasing the sample size, sample 
heterogeneity, and utilising more than one cranial practitioner to more accurately 
investigate the CV4 technique. 
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The contrast in findings between Hanten, et al., (1999), Hayden & Mullinger, (2006) 
and Milnes & Moran, (2007) is typical of the literature that surrounds OCF, 
characterised by small trials of low methodological quality.  There have been no 
studies on clinical outcome measures based upon a study of OCF designed to make 
use of the full range of techniques used to treat a targeted problem.  A scientific 
compromise exists between a treatment-oriented study and a technique-oriented study.  
The treatment-oriented study provides the truest mimic of an OCF treatment, allowing 
full autonomy in the practitioner’s choice of techniques, with high external validity 
but low internal validity.  In contrast, a technique-oriented study has a set number of 
techniques given to each participant and displays a high internal validity but low 
external validity.  A study combining aspects of both these ideals, where a treatment 
goal is given (ie, to affect the hypothalamic-pituitary axis in order to effect stress) but 
limited to a set of techniques (ie, using only techniques within OCF) might give both 
good internal and external validity. 
 
Internal Controversy surrounding Osteopathy in the Cranial Field 
 
Controversy within the osteopathic profession surrounding OCF usually targets two 
main purported physiological phenomena which are core to the validity of this 
intervention technique: motion present in cranial sutures and a palpable rhythmic 
impulse (or Cranial Rhythmic Impulse).  The most prolific authors seeking to 
discredit the use of OCF within osteopathy are S. E. Hartman & J. M. Norton.  
Hartman & Norton (2002) suggest that the primary respiratory mechanism contains 5 
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elements that need to be physiologically or biomechanically proven in order for OCF 
to be validated.  They are: 
• The inherent rhythmic motility of the brain and spinal cord 
• Rhythmic fluctuation of the cerebrospinal fluid 
• Articular mobility of the cranial bones 
• Mobility of the intracranial and intraspinal dural membranes  
• And the mobility of the sacrum between the ilia.   
 
Hartman and Norton argue that no further attention is required to debunk OCF as 
none of these afore-mentioned assumptions have been shown to be proved.  Hartman 
often uses a majority of self-authored literature in the bibliography chosen to 
construct his arguments (Hartman, 2005b, 2006a, 2006b, 2007).  He only cites his 
own review completed in 2002 as being the evidence to state that “the primary 
respiratory mechanism is invalid, inter-examiner reliability is approximately zero and 
there is no scientific evidence of clinical efficacy” (Hartman, 2005a).  He argues that 
proposed physiological mechanisms used to advocate OCF are the same “biologically 
untenable ones that Sutherland described 65 years ago” (Hartman, 2005b).  He states 
that “movement (at cranial vault sutures) is impossible in most adults”(Hartman & 
Norton, 2002) even though there are numerous papers suggesting that cranial sutures 
are deformable (Herring & Ochareon, 2005; Jasinoski, Reddy, Louw, & Chinsamy, 
2010; Pritchard, Scott, & Girgis, 1956).  Closure of cranial sutures often occurs much 
later than Hartman quotes at 12-19 years (Green et al., 1999), and is so variable it is 
not considered useful for estimating the age of a skull (Sahni, Jit, & Sanjeev, 2004) 
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Hartman & Norton (2002) also states that the bone is too heavily mineralised to allow 
palpable deformation.  However, a more recent study completed by (Cook, 2005) 
suggests that the existence of sutures, which contain more viscous mobility than 
surrounding bones (Steenvoorden, van de Velde, & Prahl-Andersen, 1990), could be 
considered evidence of a suture that can accommodate motion.  Cook (2005) argues 
that increased localised “bendability” and flexibility around the suture allows for the 
absorption of impact forces whilst maintaining the large amount of protection 
required for the brain without damaging the dura.  The presence of wormian bones 
(small ossicles within the cranial suture lines) is presented as possible evidence that 
motion occurs around a suture (Cook, 2005).   This, in general, is an opinion that is 
supported in other literature completed on strain patterns and evolution of the cranial 
suture (Jasinoski et al., 2010; Yu, Borke, & Zhang, 2004) 
 
Evidence supporting possible cranial suture, intracranial and intraspinal dural 
membrane mobility is proposed by a study measuring changes in elongation of the 
falx cerebri (in the magnitude of 1.44mm elongation to -0.33 compression) during the 
application of craniosacral therapy on an embalmed cadaver (Kostopoulos & 
Keramidas, 1992).   The review by (Green et al., 1999) found this study did not 
demonstrate adequate validity and reproducibility within their measurements. 
 
It seems, from this literature review, that there is a distinct lack of scientifically robust 
studies to either prove or negate the effects of OCF.  The osteopathic profession is in 
dire need of a large randomised controlled trial on a health effect outcome of OCF, 
funded by un-invested parties to move the evidence base either for or against OCF, 
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and to provide the practitioner with a robust scientific reason for choosing OCF as a 
treatment tool.   
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Part III : Review of Methodological Issues 
 
 
 
 
Factors that Influence Salivary Cortisol  
 
Secretion of cortisol. 
Known variables that may influence cortisol secretion are time of day (Dahlgren, 
Kecklund, Theorell, & Åkerstedt, 2009), gender (Patel, Shaw, MacIntyre, McGarry, 
& Wallace, 2004), age (Ice, Katz-Stein, Himes, & Kane, 2004), current stress levels 
(Vedhara, Hyde, Gilchrist, Tytherleigh, & Plummer, 2000), positive affectivity (Lai et 
al., 2005), affective disorders (Bhagwagar, Hafizi, & J., 2003), drugs acting on 
neuroendocrine or endocrine pathways (Pariante et al., 2004), food restriction and 
eating (Petro, 1997), and exercise (McGuigan, Egan, & Foster, 2004).  These factors 
should be controlled for as much as possible when selecting participants to take part 
in the experimental procedure. 
 
It has also been shown that chronic systemic disease can also have a significant effect 
on cortisol production.  Excessive and sustained cortisol secretion has been associated 
with diseases such as depression, hypertension, insulin resistance, atherosclerosis and 
cardiovascular disease (Chrousos & Gold, 1998).  Alcoholism and family history of 
alcoholism can depress cortisol responses to stress (Gianoulakis, Dai, Thavundayil, & 
Brown, 2005; Junghanns, Horbach, Ehrenthal, Blank, & Backhaus, 2007).  It will be 
important to consider these factors on selection of participants for any study 
measuring salivary cortisol. 
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Ethnicity (Bennett, Merritt, & Wolin, 2004), personality traits (identified as 
extraversion and neuroticism) (LeBlanc & Ducharme, 2005) and some genetic factors 
suggesting heritability of cortisol response (Kudielka et al., 2009) have been 
identified to have possible effects on cortisol secretion.   These factors are either 
difficult to control for, are tenuous, or if controlled for could decrease the 
generalisibility of this study.  Therefore this study will not attempt to control for them. 
 
Since the design of experimental procedure and participant selection for this study 
was completed it has come to light that the effects of food on cortisol response relate 
more to a significant inhibition of cortisol secretion with low glucose levels, than an 
increased cortisol response in participants with elevated glucose levels (Kudielka et 
al., 2009).  Glucose levels between participants should be standardised before 
exposure to the stressor.  
 
Relationship between serum and salivary cortisol. 
 
Cortisol, present in both serum and saliva, is an easily obtainable, non-invasive 
diagnostic outcome measure when analysed from saliva (Rantonen et al., 2000).  An 
early study performed by Vinning, McGinley, Maksvytis, & Ho (1983) shows that 
salivary cortisol levels are directly proportional to serum unbound plasma cortisol 
levels in normal individuals.  The relationship between salivary and serum total 
cortisol concentrations was found to be non-linear, with salivary cortisol levels 
increasing more rapidly once serum cortisol-binding protein was saturated (Vinning et 
al., 1983), with a relationship of 3:2 plasma to salivary cortisol levels (Vinning & 
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McGinley, 1987).   Since the relationship between serum and salivary cortisol can be 
quantified proportionally it would seem a more humane mode of sampling to take 
salivary cortisol samples than blood samples. 
 
The rate of cortisol equilibrium between blood and saliva was first shown to occur 
within five minutes (Vinning et al., 1983).  Further studies have shown that the time 
needed for passive diffusion to reach equilibrium to be closer to 1- 2 minutes 
(Kirshbaum & Hellhammer, 1994).    Keenan, Roelfsema & Veldhuis (2004) support 
Kirshbaum & Hellhammer (1994) by reporting a cortisol diffusion rate of 1.8 + 0.20 
minutes into and out of the saliva. In this same study the authors also reported total 
cortisol to have a half-life of 49 + 2.4 minutes; free cortisol to have 4.1 + 0.30 
minutes, and ACTH to have a half-life of 20 + 1.3 minutes.  With this information it 
can be assumed that salivary cortisol will be quickly indicative of plasma cortisol 
levels.  As it has a known half-life in the form of total and free cortisol an 
experimental procedure can be designed to occur within these half-life times.  Total 
cortisol represents all systemic cortisol levels, both bound and unbound, whereas free 
cortisol represents only unbound cortisol levels (Ganong, 1997).  The cortisol within 
saliva is the free cortisol component of total cortisol (Poll et al., 2007).  Free cortisol 
diffuses into and out of the saliva from plasma within two minutes, and has a half-life 
of less than five minutes before it is metabolised(Keenan et al., 2004; Kirshbaum & 
Hellhammer, 1994).  Therefore salivary cortisol should quickly and dependably 
represent the plasma cortisol levels that are present.  If the experimental procedure is 
complete before the half-life of total cortisol is complete then any change in cortisol 
level should be due to factors other than normal cortisol metabolism. 
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Salivary Cortisol Levels as a non-invasive biomarker of Stress 
 
Measuring salivary cortisol is an effective non-invasive sampling method (Kirshbaum 
& Hellhammer, 1994) that indicates differential levels of psychological and 
physiological stress in an individual (Singh et al., 2006).  Salivary cortisol 
measurements have been found to be useful in monitoring cortisol levels when 
repeated sampling of blood could be traumatising, impractical or unethical (Rantonen 
et al., 2000).  A psychological stressor was selected to illicit the stress response in this 
study. 
 
Salivary cortisol levels have been shown to be independent of salivary flow rate 
(Kaufman & Lamster, 2002). Cortisol enters the saliva via passive diffusion through 
the acinar cells of the salivary glands (Lewis, 2006), allowing sampling of salivary 
cortisol levels to accurately indicate serum cortisol levels, without the influence of a 
dilution effect from the salivary flow rate.  This indicates that using mastication to 
illicit salivary secretion (Ganong, 1997) will not effect cortisol levels within the 
saliva. 
Storage and Stability of Salivary Cortisol 
 
Studies have shown that salivary cortisol is stable during extended periods without 
freezing, even when exposed to widely varying temperatures (Clements & Parker, 
1998), as well as being stable at room temperature without centrifugation in the short 
term (Khan, Rubinow, Davis, Kling, & Post, 1988).  Salivary samples can be stored at 
five degrees Celsius for up to three months with no effect on the assessment of 
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cortisol levels (Garde & Hansen, 2005).  Storing saliva samples at room temperature 
was found to correlate a 9.2% decrease in cortisol concentration per month, and 
repeated freezing and thawing of samples up to four times before analysis did not 
effect concentration (Garde & Hansen, 2005).   
 
Conclusion  
 
The mechanism by which OCF has an impact or the clinical effectiveness of OCF still 
remains unclear.  The newly emerging hypothesis for CSF production and theorised 
vascular mechanism for homeostasis of intra-cranial pressure also requires further 
exploration.  There may be evidence to support the motion of the brain, the 
craniosacral rhythm and that cranial sutures may stay unfused for much longer than 
previously thought.  A recent large retrospective review seems to support normative 
ranges for a Cranial Rhythmic Impulse even though there is no evidence to support 
the possibility of palpation of movement of the cranial bones.  There is much left 
unclear with a lack of robust evidence to inform on the effectiveness of OCF.  The 
requirement for a large randomised controlled trial seems apparent. 
 
The professional feeling for many practitioners has been described by Moran (2005) 
as being “that there is too much anecdotal experience of a palpable cranial 
phenomenon and positive results for patients from an OCF treatment” to ignore it.  
Certainly the evidence of iatrogenic side-effects described in McPartland (1996) 
suggests that OCF must have a physiological mechanism, even if that mechanism 
remains unclear to evidence based medicine as yet. 
 
45 
It is suggested by some that craniosacral therapy should be abandoned (and with it 
OCF) due to a lack of evidence of efficacy after more than 50 years of research 
(Flynn, Cleland, & Schaible, 2006).  However as most of the research to date is 
scientifically weak it stands to reason that further investigation is required before 
evidence based decisions can be made either way.   
 
Moran (2005) is quoted as saying “how does it work?” is less important that “does it 
work?” in the context that a detailed investigation of cranial suture movement, or the 
ability of the human to detect cranial suture movement by palpation alone, would 
needlessly consume resources when it may still be discovered that clinical efficacy is 
limited.  It is the aim of this research project to provide a pilot study with a technique 
based protocol entailing a moderate amount of practitioner autonomy in treatment 
choices.  This study will utilise both a subjective (self-reported stress levels) and 
objective (salivary cortisol) outcome measures to investigate the effects of a session 
of OCF on stress when compared with a sham procedure. 
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Abstract 
 
Introduction:  Stress, both physical and psychological, has the ability to influence 
physical health outcomes.  Within Osteopathy in the Cranial Field (OCF) there are 
claims that OCF can be used to effectively treat stress.  The aim of this pilot study 
was to investigate the effect of an OCF session on salivary cortisol and subject self-
reports of stress when compared to a sham procedure.  
 
Methods:  A single blind, placebo-controlled, cross-over experimental design was 
used.  At the same time on consecutive days, participants who were naïve to OCF 
received two 20-minute interventions, either cranial treatment or sham, administered 
in random order to which both practitioners and were blinded, following a mental 
computation task, given after initial measurements and before interventions, known to 
induce psychological stress.  Salivary cortisol and self-reported stress scores (SRSS) 
were collected before and after the stress task (Initial and Pre-Intervention samples) 
and after each intervention (Post-Intervention sample).   
 
Results:   Ten participants (5 male; 5 female) with a mean ± SD age of 36.9 ± 8.0 
years completed the study. Group data analysis identified trivial differences in 
salivary cortisol levels between Initial, Pre-intervention and Post-intervention samples 
(p = 0.37) and between cranial and sham interventions (p = 0.64).  Analysis of SRSS 
revealed large differences between Initial, Pre-intervention and Post-intervention 
samples (p<0.001), but trivial differences between sham and cranial interventions (p = 
0.89).  After the sham intervention five participants had a ‘moderate to large’ increase 
in salivary cortisol, two had a ‘trivial’ to ‘small’ change in cortisol, and five had a 
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‘moderate’ to ‘large’ decrease in cortisol.  For the cranial intervention three 
individuals experienced a ‘moderate’ to ‘large’ increase in cortisol, two had a ‘trivial’ 
to ‘small’ change in cortisol and five had a ‘moderate’ to ‘large’ decrease in cortisol.  
The mental computation task did not induce a consistent cortisol stress response for 
either intervention (Intraclass r = 0.04; Pearson’s r = 0.11), and there was a weak 
correlation between stress ratings and salivary cortisol levels (Pearson’s r = 0.25; p = 
0.04).  
 
Conclusion:  Preliminary data analysis indicates that whilst participants reported they 
were stressed by the computation task, the task failed to stress them reliably.  
Although participants reported less stress after both the sham and the OCF 
intervention, salivary cortisol levels did not change, nor was there any difference in 
either participant-reported stress rating or cortisol levels between the cranial and sham 
interventions.  Individually, most participants had some change in salivary cortisol in 
response to both interventions (increase or decrease), but there was no evidence to 
indicate that the cranial intervention decreased cortisol levels more than the sham 
intervention.  This study failed to find evidence to support claims that OCF can have a 
positive effect on psychological stress. 
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Introduction  
 
The term stress can be used to describe eustress (everyday stress),1 distress (more 
extreme stress impacting on homeostasis).1  In addition ‘stress’ can be used to refer to 
either the stressor or the stress response itself.  The present study will use the term 
stress to describe the hormonal stress response mediated through the hypothalamic-
pituitary-adrenal axis that occurs from exposure to a stressor.2  
 
In the short term psychological stress can have a protective role, providing stimuli for 
‘fight or flight responses’ and adaptive hormonal responses to maintain systemic 
homeostasis.3  However excessive or chronic stress can have a maladaptive, 
widespread influence on health outcomes, which present clinically with a diverse 
range of clinical presentations.3-5  Workplace stress is an important issue. In New 
Zealand, legislation for the management of workplace stress has been developed and 
infringements successfully prosecuted.6      It is therefore a priority to investigate 
treatment modalities that are readily accessible and claim to treat stress, such as 
Osteopathy in the Cranial Field (OCF).7,8 
 
The basis for OCF, also referred to in literature as cranio-sacral and cranial 
osteopathy,9 was developed during the first two decades of the 20th Century by 
Sutherland.7  The foundational principles of OCF postulated by Sutherland include a 
complex interaction between cerebral spinal fluid, the function of the dura mater and 
its internal extensions through the brain, the motility of the neural tube and the 
mobility of the cranial bones.7,10 Treatment goals within OCF include “counteracting 
stress-producing factors by normalising function of the cerebrum, thalamus, 
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hypothalamus and pituitary body”.11   What is perceived to be stressful, and the 
response, both behavioural and hormonal, to that stress is centrally mediated4 through 
the paraventricular nucleus in the brain, the locus coeruleus-norephinephrine in the 
brain stem2 and the hypothalamic-pituitary-adrenal axis.12  Therefore it seems that 
proponents of OCF claim that they are able treat stress by targeting components 
within the central nervous system that are involved in the stress response. 
 
There are ongoing controversies surrounding the physiological mechanisms by which 
OCF may have an effect.  A comprehensive systematic review performed in 19999 has 
concluded that studies investigating OCF are methodologically weak, and there have 
been few studies since then that would influence this conclusion.  There are scant data 
on the physiological14 or clinical outcomes of OCF.13-15   Further controversies arise 
in diagnostic reliability;16-20 movement of cranial bones21 and whether OCF positively 
influences health outcomes.14,15  Despite ongoing controversy regarding the scientific 
basis for this practice22 and the apparent lack of support within the scientific literature, 
the clinical practice of OCF persists and is offered by osteopaths in the UK, the US, 
Australia and New Zealand.     
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Salivary cortisol has been used as a non-invasive measure of stress23 that can 
objectively indicate levels of psychological stress in an individual.12 Cortisol is a 
glucocorticoid steroid that is secreted from the adrenal gland in response to 
stimulation from adrenocorticotrophic hormone (ACTH).  ACTH is then secreted by 
the pituitary gland after stimulation from corticotrophic releasing factor (CRF) 
produced by the hypothalamus in response to a stressor.24  The aim of the present 
study was to investigate the effect of an OCF session on salivary cortisol and 
participant self-reports of stress when compared to a sham procedure.  
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Methods 
 Design. 
A single blind, placebo controlled, crossover experiment, was employed to explore 
the effect of OCF on stress as measured by salivary cortisol levels and Self-Reported 
Stress Scores.   The design of this intervention was based aspects of a previous 
study.25  This study was conducted at the Teaching Clinic, within the Department of 
Osteopathy in School of Health, Unitec, Auckland, New Zealand and was approved 
by the Unitec Research Ethics Committee, [Appendix I]. 
 
Twelve subjects, one OCF practitioner with specific OCF post-graduate training and 
experience (more than two years), one  research assistant as the sham operator and 
one stress task operator (independent to the OCF and sham practitioners) took part in 
the study.  Criteria for recruitment of the sham operator included; a competent level of 
capability in manual therapy (to ensure fluid and confident handling of participant’s 
heads), no prior formal or informal training in OCF, coach-ability in OCF hand holds, 
the same gender as the OCF Practitioner; and hands of a similar overall size and 
appearance to the OCF Practitioner.  A third year osteopathic student, in the Bachelor 
of Applied Science in Human Biology at Unitec, was recruited as the sham operator.  
Each participant received two independent interventions in the form of an OCF 
treatment and controlled sham treatment.  Experimentation was conducted on two 
consecutive days at the same time of day.  
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Participants. 
Adults between the ages of 20 and 60 years were recruited by convenience and 
snowball sampling methods.  
Participants were excluded from the investigation if they: 
1) Had received any prior OCF treatment 
2) Held beliefs or knowledge about what OCF treatment comprises 
3) Had taken medications that affect salivary cortisol levels  
4) Had a history of any endocrine, neuro-endocrine or psychiatric 
disorders  
5) Had contraindications for receiving OCF (as deemed by the OCF 
practitioner)  
6) Self reported regular high or low stress level [See Appendix II]  
7) Were unable to give an informed consent to participating in the study 
[shown in Appendix Figure III]  
 
All participants read and understood information about the study [supplied in 
Appendix II] and gave written consent to take part [see Appendix III]. 
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Procedure. 
The experimental procedure is outlined in Figure (1) below. 
 
 
 
Figure 1.  Procedural Flowchart. 
Procedural flowchart displaying sampling, stress task and intervention order.  
Notes:  SRSS = Self-Reported Stress Scores, used as participant-reported 
subjective VAS rating, OCF = Osteopathy in the Cranial Field. 
  
 
 
As shown in the procedural flowchart Initial (Figure 1) salivary cortisol and Self-
Reported Stress Scores (SRSS) scores were collected 5 minutes after subjects arrived 
Repeat 1x  
20 mins of OCF or sham 
treatment 
Wash out 
time (1day) 
Post-intervention salivary 
cortisol and SRSS 
collected 
Pre-intervention salivary 
cortisol and SRSS collected 
 
6 min Stress task 
(PASAT) 
Post-intervention 
salivary cortisol and 
SRSS collected 
 
Performance of 
remaining 
intervention 
1st Intervention 2nd Intervention 
Initial salivary cortisol sampled 
and SRSS score collected 5 mins 
after arrival 
Baseline VAS 
END 
Day One Day Two 
Pre-intervention salivary 
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at the clinic.  Subjects were then exposed to a 6 minute stress task, 3 minutes after 
which saliva and SRSS scores were collected again.  Subjects were then lead into a 
separate room in which they received a 20 minute intervention, and gave saliva 
samples and SFSS collected a third time immediately following the intervention.  This 
process was repeated on two consecutive days, with subjects receiving one 
intervention type on day one and the alternate on the second day.  Participants were 
asked to refrain from eating, drinking, smoking or exercising for at least two hours 
prior to experimentation.   All experimentation was carried out between the hours of 
9am and 4pm. 
 
 Allocation and blinding. 
Subjects were divided into two groups to receive interventions in two different orders 
(cranial first, then sham or vice versa) by the flip of a coin.  Subjects were randomly 
divided into the different groups until one group contained six subjects.  The 
remaining subjects were then divided to the other group. 
 
Subjects were blinded to the presence of a sham intervention, and the OCF and sham 
practitioners remained behind a curtain at all times, with only their arms distal to the 
elbow exposed to the subject.  Hence, the practitioners were blinded to the identity of 
each subject and unaware of the order of the presentation of the intervention they 
were applying.  All care was taken to ensure that subjects did not identify the 
existence of two different practitioners during experimentation.  Investigator blinding 
took place using a labelled number system on all saliva samples and self-reported 
stress scores sheets. 
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Cranial intervention. 
The OCF practitioner was asked to “affect the hypothalamic-pituitary axis” in 
whatever way they deemed appropriate for any given subject who lay in the supine 
position.  The practitioner was allowed to use their discretion in applying OCF 
techniques to achieve the treatment goal because this was thought to most closely 
simulate normal clinical decision making process. 
 
Sham intervention. 
During the sham intervention the subject lay supine on the same plinth, in the same 
room as the cranial intervention.  The sham operator changed their head contacts on a 
schedule defined by a visible timer (frequency of one change per five minutes, set to 
approximate the frequency used by OCF practitioner).  Within the OCF community it 
has been anecdotally asserted that ‘intention’ (ie, non verbalised thought processes) of 
the practitioner may influence clinical outcomes.  In an attempt to control for the 
possibility of an intention effect the sham operator was distracted by watching a 
movie, using sound cancelling headphones.  
 
Mental computation stress task. 
Prior to receiving intervention each subject was required to perform a serial 
summation of two digits presented orally by the Paced Auditory Serial Addition Task 
(PASAT) computer programme (PASAT, Cleveland Clinic: Cleveland, Ohio).  The 
subject was asked to add the last digit to the next digit after calling out the answer to 
the previous equation.  The subjects were therefore required to remember the last digit 
called, to answer the equation, and listen for the next digit simultaneously.  This 
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process was repeated under time pressure (0.4 seconds per orally presented digit).   
The operator of the PASAT stood behind the seated participant, recording all answers 
and informing the participant of answers.  To increase the level of mental stress 
experienced by the participant the operator informed participant of the accuracy of 
their response.  When participants were able to give a high number of correct answers 
the operator falsely informed the participant that some answers were incorrect.   
 
Measures. 
Cortisol enzyme immunoassay.  
 
 
The assay chosen to measure the concentration of salivary cortisol was the ACETM 
Competitive Enzyme Immunoassay Cortisol EIA Kit (catalogue number 582121, strip 
plate, Cayman Chemical Company: Ann Arbor, Michigan).  This enzyme 
immunoassay has been developed specifically for research purposes using plates pre-
coated with mouse monoclonal antibodies that are specific for the antibody to cortisol.  
Quantification of cortisol concentration is based on competition between cortisol and 
a pre-prepared cortisol-acetylcholinesterase (AChE) conjugate (cortisol tracer) for a 
known, limited number of rabbit antiserum binding sites.  According to the 
manufacturer, cortisol is assayed with 100% specificity and all protocols were 
performed according to the provided instructions. 26 
 
As no “stop development” solution was included in the design of this assay plate one 
was read twice (once at the beginning, and then again after all plates had been read) in 
order to ascertain levels of consistency for the duration of the laboratory procedure. 
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Self-Reported Stress Scores. 
 
Intensity of stress was measured using the self-reported VAS scale.  A 100 mm 
horizontal line, graduated and numbered every 10mm, from 0 (no stress) to 10 (most 
stress ever experienced) was presented to subjects on which to score their level of 
stress at that time  [Appendix IV].  The scale design used in this study was based 
upon findings presented in previous work.27  All completed scales were hidden from 
view of the subject to reduce the chance of direct comparison with previous stress 
ratings. 
 
Reduction of raw data from cortisol immunoassay. 
Data Analysis of Cortisol Immunoassay 
Analysis of the EIA was performed using proprietary analysis software (KC Junior, 
Bio-Tek Instrument Inc: Winooski, Vermont).   Manual calculations of immunoassay 
data collected during the immunoassay were also carried out.  There were only trivial 
differences in measured cortisol concentration between calculation methods so all 
statistical analyses were performed using KC Junior data.  [Raw data and 
transformation calculations used are presented in Appendix V]. 
 
The 1:20 dilution data, from a serial dilution, were used to obtain average cortisol 
concentrations for each saliva sample taken as this had the least laboratory errors, and 
the highest number of concentrations that could be read accurately from the generated 
standard curve [see appendix VI for the standard curve and appendix VII for all 
subsequently measure cortisol concentrations] 
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Cortisol concentrations outside of known reported cortisol ranges28,29 were not 
included in analysis [indicated in Appendix VII].   
 
Statistical analysis. 
Group data analysis. 
Treatment-related changes in cortisol levels and self-reported stress ratings were 
explored using repeated measures, two-way analysis of variance (ANOVA) for sham 
versus cranial and time-point cortisol changes.  Effect sizes were calculated according 
to Cohen’s d formula in Hopkins30 procedure and were reported for the change in 
each variable.  The relationship between self-reported stress ratings and cortisol levels 
was assessed using a Pearson’s r correlation coefficient (PCC).  All measures are 
reported as mean ± 95% confidence intervals, unless otherwise indicated. 
 
Individual data analysis. 
 
Effect sizes of individuals’ cortisol response to both the stress task (calculated by the 
change in cortisol from Initial to Pre-Intervention samples) and the sham and cranial 
interventions (calculated by the change in cortisol from Pre-Intervention to Post-
Intervention samples) were calculated.   
 
All effect sizes for each participant were categorised by defining participants as 
positive, non- and negative responders and grouped in accordance with response to 
the cranial intervention.  For the purposes of this experiment a ‘positive responder’ 
was defined by a positive ‘moderate to large’ effect size (0.61 to 2.0 effect size in 
positive direction i.e. cortisol increase) on the magnitude scale developed by 
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Hopkins31 [see Appendix X].  A ‘non-responder’ was defined as having a positive or 
negative ‘trivial to small’ effect (0 to 0.60 effect size in a negative or positive 
direction i.e. a non-substantial cortisol increase or decrease), and a ‘negative 
responder’ was classified as having a negative ‘moderate to large’ effect (-0.61 to -2.0 
effect size in a negative direction i.e. cortisol decrease).   
 
Reliability of the effect of the stress task on cortisol levels and laboratory 
procedure. 
 
 
The reliability of the effect on the PASAT stress task was assessed by reporting the 
ICC for cortisol change from Initial to Pre-Intervention time-points between the two 
trials conducted for each participant prior to each experimental condition. Negative 
numbers were removed from the data in the following way:  If both values were 
negative (ie cortisol levels reduced following stress task) then the absolute values of 
both were used.  If only one value was negative the pair of numbers was calculated by 
using the absolute value of the negative number as the first member of the pair, and 
adding to this absolute value of the difference between the paired changes in cortisol 
concentration from the two trials to provide the second member of the pair.  For 
example when the paired changes in cortisol concentration were -303 pg/ml and 972 
pg/ml, the resulting pair became +303 pg/ml and [+303+|(-303 – 972)| = ] 1578pg/ml.  
The first reading of plate one was compared to the second reading, using a second 
ICC in order to investigate reliability of laboratory procedure.  This explored whether 
the continued action of the reagent in the EIA, in the time taken to read all plates, had 
resulted in a continued development of colour and a significant shift in the read 
absorbance and calculated concentrations in subsequently read plates. 
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Results 
Twelve healthy male (n = 6) and female (n = 6) subjects (mean age 36.9 years, range 
23 – 49 years) enrolled in this study.  Two participants were currently smokers, and 
the rest had not smoked at all for at least two years.  One subject failed to present to 
their second intervention due to family bereavement, and first intervention data from 
another were not analysed because of spoilage.  In total, data from ten participants 
who completed all parts of this study (5 females, and 5 males) were analysed. 
 
Group data. 
Levels of salivary cortisol from the 1:20 dilution analyses did not alter appreciably 
across the three sampling points in the experimental protocol (Initial, Pre-Intervention 
and Post-Intervention) (p = 0.5) and there were no differences between conditions (p 
= 0.4) and no difference in the response over time between sham and cranial 
experimental conditions (p = 0.8; Figure 2).  Mean cortisol levels did trend in an 
upwards direction between Initial and Pre-Intervention measurements and mean 
cortisol decrease between Pre- and Post-Intervention measurements tended to be 
greater in the cranial compared to the sham condition but in both cases the effect sizes 
were trivial (ES = 0.2 and -0.3 respectively) and might have been due to chance.  
Performing these analyses using 1:20 and 1:80 dilution data combined did not affect 
the results [data not shown, see Appendix VIII]. 
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Figure 2.  Comparison of cortisol levels over time-points in 1:20 dilution data set.   
Notes: Error bars represent standard deviations.  Time-points are not represented 
linearly for ease of comparison. 
 
SRSS showed substantial variation over the three sampling time-points (p < 0.001), 
increasing markedly between the Initial and Pre-Intervention measurements (ES = 
2.6) and then dropping sharply between Pre- and Post-Intervention measurements (ES 
= -4.1) (Figure 3).  However there were no differences between conditions (p = 0.7) 
nor was there an appreciable time x condition interaction effect (p = 0.6), meaning 
that there was no difference between conditions in the change in SSRS over time  
(Figure 5). 
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Figure 3.  Comparison of self-reported stress ratings over time-point.   
Notes: Error bars represent standard deviations.  Time-points are not represented 
linearly for ease of comparison. 
 
There was a ‘small’ relationship between SRSS and cortisol concentrations pooled for 
all participants at each time-point (Pearson’s r = 0.25, p = 0.04).  These data are 
presented below in Figure (4).   
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Figure 4.  Relationship between individual objective cortisol levels and subjective 
self-reported ratings of stress.   
Notes:  VAS = Visual Analogue Scale used to rate SRSS. 
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Re-analysis of both SRSS and cortisol data after converting to change from Initial 
levels did not affect outcomes [data not shown, see Appendix IX]. 
Individual Data Analysis 
 
In order to further explore individual responses in cortisol and SRSS to the 
experimental procedure protocol data were also analysed on an individual participant 
basis. 
 
All individual results are summarised in Table 1, with a summary of effect size with 
response type in Table 2.   
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Table 1.  Individual Cortisol Levels and Self-Reported Stress Scores.  
Individual results for salivary cortisol and participant-reported SRSS scores for all 
participants 
Subject 
Intervention 
Type Initial Pre-Intervention Post-Intervention 
Change from 
Initial to Pre-Int 
Change from 
Pre-Int to Post-
Int 
    Cortisol SRSS Cortisol  SRSS Cortisol SRSS Cortisol SRSS Cortisol   SRSS 
1 Sham 4431 30 5689 70 6324 10 1258 40 635 -60 
 F, S Cranial   10   70   20   60   -50 
2 Sham 2759 10 6129 60 6612 0 3370 50 483 -60 
 M, NS Cranial 4065 20 5915 60 8589 10 1850 40 2674 -50 
3 Sham 8172 40 10076 60 9131 10 1903 20 -944 -50 
 M, NS Cranial 7806 30 8990 70 6103 10 1184 40 -2887 -60 
4 Sham 7757 50 7536 50 5671 40 -221 0 -1865 -10 
 F, NS Cranial 7090 70 8732 80 7462 60 1641 10 -1270 -20 
5 Sham 6905 10 7065 60 5198 0 159 50 -1867 -60 
 F, NS Cranial 4493 10 4195 50 3115 0 -297 40 -1080 -50 
6 Sham 9617 40 11310 70 8862 15 1693 30 -2448 -55 
 M, S Cranial 6081 35 6355 70 6060 10 274 35 -295 -60 
7 Sham 5590 20 4641 50 4751 5 -949 30 110 -45 
 F, NS Cranial 8646 30 8726 70 6518 5 80 40 -2208 -65 
8 Sham 1312 10 2563 50 3341 20 1251 40 778 -30 
 F, NS Cranial 4245 10 3709 70 4566 0 -536 60 857 -70 
9 Sham 4201 5 4030 80 7513 5 -171 75 3484 -75 
 M, NS Cranial 5431 0 6957 60 5079 0 1526 60 -1878 -60 
10 Sham 11844 20 7877 45 6085 10 -3967 25 -1792 -35 
 M, NS Cranial 5501 25 8068 30 4611 20 2567 5 -3457 -10 
11 Sham 3973 60 6070 90 6802 50 2098 30 731 -40 
 M, NS Cranial                 
12 Sham 3705 20 3976 60 2767 0 271 40 -1208 -60 
 F, NS Cranial 4012 0 2492 60 3585 0 -1520 60 1093 -60 
Notes:  All cortisol concentration provided in pg/ml, and SRSS scores in mm.  Pre-Int = Pre-Intervention sample, Post-Int = 
Post-Intervention sample, M = Male, F = Female, S = Smoker, NS = Non Smoker.  All smokers responded positively to the 
question “have you smoked at all in the past two years”. 
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Table 2.   Individual Effect Sizes and Self-Reported Stress Scores. 
Individual effect sizes catalogued as positive, non- and negative responders and then 
grouped as per individual response to the cranial intervention. 
 
Interventio
n Type 
Effect Size 
from Initial 
to Pre-Int 
Response 
from Initial to 
Pre-Int 
SRSS 
change after 
Stress Task 
Effect Size 
from Pre-Int 
to Post-Int 
Response from 
Pre-Int to Post-
Int 
SRSS change 
after 
Intervention 
Positive Responder to Cranial Intervention 
Subject 
2 Sham 1.72 + 50 1.34 + -60 
  Cranial 1.26 + 40 1.31 + -50 
Subject 
8 Sham 1.61 + 40 1.44 + -30 
  Cranial -1.12 - 60 1.42 + -70 
Subject 
12 Sham 0.74 + 40 -1.57 - -60 
  Cranial -1.68 - 60 1.46 + -60 
Negative Responder to Cranial Intervention 
Subject 
3 Sham 0.89 + 20 -0.47 N -50 
  Cranial 1.31 + 40 -1.58 - -60 
Subject 
5 Sham 0.37 N 50 -1.64 - -60 
  Cranial -0.74 - 40 -1.29 - -50 
Subject 
7 Sham -1.63 - 30 0.54 N -45 
  Cranial 0.19 N 40 -1.72 - -65 
Subject 
9 Sham -1.2 - 75 1.49 + -75 
  Cranial 1.72 + 60 -1.69 - -60 
Subject 
10 Sham -1.69 - 25 -1.51 - -35 
  Cranial 1.61 + 5 -1.65 - -10 
Non Responder to Cranial Intervention 
Subject 
4 Sham -0.06 N 0 -0.7 - -10 
  Cranial 0.77 + 10 -0.53 N -20 
Subject 
6 Sham 1.41 + 30 -1.53 - -55 
  Cranial 1.18 + 35 -0.57 N -60 
No Results from Cranial Intervention 
Subject 
1 Sham 1.41 + 40 1.01 + -60 
  Cranial     60     -50 
Subject 
11 Sham 1.44 + 30 0.81 + -40 
  Cranial             
 
Notes:  + = positive responder (Effect Size range 0.61-2.0), N = non-responder (Effect Size range 0 - 0.60), - = negative 
responder (Effect Size range -0.61 + -2.0) 
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Eight of the ten participants that completed this study had some response (either as a 
positive or a negative responder) to the cranial or the sham interventions.  When 
grouped in accordance with response to the cranial intervention 5 of the 10 subjects 
that completed the study were negative responders.  Of those 5 participants, three 
(subjects 3, 7 and 9) were either non- or positive responders to the sham intervention; 
and two (subject 5 and 10) were negative responders to both the sham and the cranial 
intervention.  Of the three participants (participants 2, 8 and 12) that were positive-
responders to the cranial intervention two were also positive-responders to the sham 
intervention; the remaining participant (participant 12) was a negative responder to 
the sham intervention.  Both participants (4 and 6) that were non-responders to the 
cranial intervention were negative responders to the sham intervention.   
 
Three participants were consistently positive responders in both exposures to the 
mental computation stress task, as measured by change of cortisol from Initial to Pre-
Intervention effect size.  It is note worthy that subject 10 had an elevated Initial 
cortisol level before their first exposure to experimental procedure, no indication of 
this stress level is given by the SRSS’s and no cause was made known to the 
examiner.   No apparent trend in response to stress task is noted within individual 
results.   
 
Ten of 12 participants recorded an increase in self-reported stress ratings of more than 
20mm from Initial to Pre-Intervention ratings following both exposures to the stress 
task (means = 36 mm for sham and 39 mm for cranial), and a decrease in SRSS’s of 
more than 20 mm from Pre-Intervention to Post-Intervention ratings following both 
interventions (means = -48 mm for sham and -51 mm for cranial). 
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No trend was observed between individual SRSS and individual effect sizes.  From 
Initial to Pre-Intervention ratings 6 individuals recorded sizeable increase in SRSS (of 
more than 20mm) yet were either non-responders or negative responders to the same 
stress task exposure between Pre- and Post-Intervention.  From Pre- to Post-
Intervention time-points 10 individuals recorded a sizeable decrease in SRSS but were 
either non-responders or positive responders to the intervention.   
 
In summary 13 from a total of 22 exposures to the stress task resulted in subjects 
being positive responders, 9 from a total of 22 resulted in subjects being negative or 
non-responders.  Following the sham intervention 5 individuals were positive 
responders, 2 were non-responders and 5 were negative responders.  For the cranial 
intervention 3 individuals were positive responders, 2 were non-responders and 5 
were negative responders.  [See Appendix XI for further information] 
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Reliability of the Effect of the Stress Task on cortisol levels and 
Laboratory Procedure  
 
 
Using qualitative standards for interpretation of ICC’s developed by Hopkins32 the 
Intraclass Correlation Coefficient showed poor consistency of cortisol response to the 
stress task between first and second trials conducted prior to the intervention (ICC = 
0.04).  The upper and lower 90% confidence limits ranged from -0.53 to 0.58.  
 
Excellent consistency existed between the first reading of plate one and the second 
reading of plate one, (ICC = 1.00).  Upper and lower 90% confidence limits were 
0.998 to 1.00. 
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Discussion  
 
It is well known that stress has the ability to widely affect physical health outcomes.  
The brain is considered the central organ of the stress response, determining what is 
deemed stressful and the response to those stressors, both psychological and 
physiological.4  The aim of this pilot study was to investigate if an OCF session can 
have an effect on stress as measured by the salivary cortisol response and subject self-
reports of stress.  This study showed that even though subjects subjectively reported 
less stress after both the sham and cranial interventions, the salivary cortisol response 
did not reflect this.  There was also no evidence to indicate that subjects responded 
differently to a cranial intervention than to a sham.  This study failed to find evidence 
to support claims that OCF can have a positive effect on stress. 
 
Two previous outcome-measure-based studies using OCF interventions have focused 
on the CV-4 technique within OCF as a treatment based investigation into the efficacy 
of OCF.13,14  The present study was not limited to one technique, and as such has only 
limited comparability with these studies.  Hanten, et al.,14 suggests that the CV-4 
technique can decrease the intensity and affective components of pain associated with 
tension-type headaches.  However the Milnes & Moran13 investigation failed to find 
evidence from autonomic effects (such as heart rate variability, respiration rate, skin 
temperature, and galvanic skin resistance) to support the commonly theorised 
autonomic effects of the CV-4 technique.  Like the experiment reported by Milnes & 
Moran the current technique study failed to find evidence to support OCF.   
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Whilst there were no meaningful differences in treatment effect between the cranial 
and sham intervention group means most individuals within this study had a moderate 
to large response to both interventions (either an increase or decrease in cortisol).  
Cortisol response to interventions and to the stress task differed considerably both 
between and within participants.    
 
Based on previous literature the 24 hour wash-out period between sessions was 
sufficient to completely metabolise evoked cortisol response between sessions.33 This 
would have removed any direct residual effects of cortisol secretion from one 
experimental procedure to the next.  
 
The variability in cortisol response may have arisen in response to several factors 
including:  familiarisation with the interventions after repetition of interventions;34 
blood glucose status;35 and a lag in the cortisol response.36  Recently, a large study (n 
= 251) investigating correlations of psychological and endocrine stress responses 
recorded a 15-minute lag between the release of ACTH from a psychosocial stress 
task and the production of cortisol, which reached a peak 15 to 20 minutes later.36  
This lag may partly explain inconsistent findings within both the Initial to Pre-
Intervention and Pre-Intervention to Post-Intervention cortisol changes.  Initial and 
Pre-Intervention samples may have been measuring the cortisol response to an 
unknown stressor occurring 15 to 20 minutes prior.   Furthermore, Post-Intervention 
samples may have been recording levels of cortisol arising from the stress task given 
approximately 26 minutes earlier.  A short time-frame of 40 minutes for the 
experimental protocol (between Initial and Post-Intervention cortisol measurements) 
used in the current study was based on a 50 minute half life of total cortisol, based on 
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data available at the time of the protocol development.33   Participants would have 
passed through all experimental procedures before a decrease in salivary cortisol 
could be attributed to metabolism.   
 
In an attempt to illicit an initial state of stress, a mental computation task called the 
Paced Auditory Serial Addition Task (PASAT) was presented to each participant as a 
simple yet frustrating task to increase levels of mental stress.37  This task was 
originally designed in 1974 by Gromwell & Sampson to measure cognitive function 
after a traumatic brain injury38 and has been previously shown to induce a cortisol 
response.39  This test has subsequently become an accepted mental stressor and has 
been used in a range of other studies.37,40,41  During the present study the PASAT did 
not reliably induce stress in individuals, as demonstrated by the large variability of 
change in salivary levels in both participants and exposures. The PASAT did 
subjectively stress individuals, as demonstrated by consistently large increases in self-
reported stress ratings perceived stress scores following the stress task. 
 
It was assumed that salivary cortisol levels would accurately indicate plasma cortisol 
levels42 within 1 to 2 minutes of the stress response.43,44  Any changes to salivary 
cortisol after the 6 minute mental computation stress task should indicate accurately 
the circulating cortisol stress response of that participant at the time of sampling, 
taken 6 minutes after the stress task.  It could be postulated that since the stress task 
has previously been successfully utilised in many different studies, and accurately 
indicates plasma cortisol levels, the variability in the stress response to the stress task 
could be due to uncontrolled variables, or simply that participants did not find the task 
equally stressful at each exposure.   
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Self-reported stress ratings may have been affected by participants reporting the stress 
levels they thought the researches expected.  Attempts were made to control the 
chances of this occurring by hiding previously rated self-reported stress scales, 
however with such a small number of ratings per experimental procedure and short 
time frames between ratings participants may have remembered what they had 
previously scored and rated subsequent scales accordingly.   
 
Interestingly, in the large interventional study exploring the correlation between the 
psychological and endocrine responses associated with different pharmacological and 
psychosocial stressors previously mentioned,36 a correlation  of anxiety as measured 
by the State-Trait Anxiety Inventory-State Version with salivary cortisol levels as 
measured by an enzyme linked immunosorbant assay (r = -0.41, p = ,0.001 for 
pharmacological stressor; r = -0.36, p < 0.001 for psychosocial stressor) was noted.  
Both the pharmacological and psychosocial stressors evoked a stress response where 
higher cortisol levels were associated with a lower anxiety states 5 to 15 minutes later.  
The authors proposed that these results might be due to an anxiety reducing effect of 
cortisol.  If acute cortisol does result in reductions in subsequent perceptions of stress 
it may help to explain the low subjective stress reports during both the sham and the 
cranial interventions, irrespective of salivary cortisol levels. 
 
Habituation of the cortisol response to methodological procedures is known to occur 
rapidly after a repeated exposure to initially stressful situations.34  In the present study 
there was no observed blunting of cortisol response between exposures to the mental 
computation stress task.  The variability in response to the mental computation stress 
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task remained high in both the first and second exposures.  The lack of habituation 
demonstrated here may be for a number of reasons. Firstly the stress task was only 
performed twice, which may not have allowed any habituation effects within the 
hypothalamic-pituitary axis to show convincingly in the data set.  Secondly, the 
effects of the stress task may have been masked either by habituation not always 
occurring consistently across participants,34 or by the lag between stressor and 
salivary cortisol response, demonstrated by Scholtz, et al.,36 influencing the response 
measured by the change in cortisol from Initial to Pre-Intervention samples.  Another 
possibility is that participants did not find the stress task stressful; however this would 
seem unlikely due to the high self-reported stress ratings given by participants. 
 
The Visual Analogue Scale was selected as a commonly used validated, reliable 
easily reproducible and easy to use45,46 subjective measure of SRSS.    These SRSS 
provided a subjective comparison for the objective measure of stress taken with the 
salivary cortisol samples.  Participants showed a substantive increase in subjective 
stress from Initial to Pre-Intervention time-points as measured by SRSS, yet the 
objective measure provided by salivary cortisol showed no such increase.   
 
Cortisol levels may have been affected by consumption of food, exercise, medications 
and health impairments, expectation bias, and extreme high or low self diagnosed 
stress levels.  Attempts were made to control for these variables with restrictions on 
food and exercise, exclusion criteria, and participant and practitioner blinding.  A 
recent review of determinants of cortisol response to different kinds of laboratory 
stimuli and variable affects has highlighted that low glucose levels appear to 
significantly inhibit the cortisol response.35  This effect was first noted by 
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Kirschbaum, et al.,47 when glucose-treated participants showed a large cortisol 
response to a stressor; and then by Gonzalez-Bono, Rohleder, Hellhammer, Salvador 
& Kirschbaum,48 who noted that saliva cortisol levels and net increases were greater 
in a group given glucose one hour before experimentation as opposed to groups given 
protein and fat.  Kudielka, et al.,35 surmise these data gathered in the two 
aforementioned studies may suggest that there is a central mechanism that regulates 
energy balance and Hypothalamic-Pituitary-Axis activation.  The present study 
attempted to control for the effect of protein in food acting as a cortisol stimulating 
agent49 by restricting food intake for two hours prior to experimentation.  However 
the possible large inhibitory effect of low nutritional status, short-term fasting and 
blood glucose levels on the hypothalamic-pituitary axis and salivary cortisol response 
was not controlled for.  This may have had a large effect on the cortisol response and 
the variability noted between and within participants in this study. Standardisation of 
blood glucose status should occur before experimentation investigating salivary 
cortisol responses.  
 
Other variables that may have significantly affected the cortisol response are both 
acute and habitual smoking,35 possible effects of alcohol dependency and family 
history of chronic alcohol consumption,50-52 possible effects of personality traits,53 and 
the influence of genetic factors on expression and variability in salivary cortisol 
responses to psychosocial stress.35 Genetic factors that may affect cortisol response 
are as yet too loosely defined and not easily controlled for.  Nicotine is a potent 
stimulator of the HPA axis35 and an attenuated cortisol response is associated with 
habitual smoking54 and a family history of alcoholism and chronic alcohol 
consumption.  The cortisol spike associated with acute smoking was controlled for by 
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asking participants to refrain from smoking for two hours prior to experimentation.  
The attenuated cortisol response from habitual smoking and associated with alcohol 
consumption, and the affect of genetic factors was controlled for by using the cross-
over methodological design, allowing each participant to be their own control.    
Subject 10 showed an unexplained elevated cortisol level (11843 pg/ml) on Initial 
sampling and rated a low self-reported stress rating (20 mm).  This participant was a 
non-smoker, and as such explanations for this cortisol level may included that they 
did not have adhered to instructions regarding food intake and experienced a spike 
associated with the intake of protein, or they may have had a stressful experience 
within the last 20 minutes that they were no longer subjectively experiencing stress 
from. 
 
The limitations of this study include a small sample size along with highly variable 
cortisol stress responses both between and within participants.  The small sample size 
(10 participants), and the large confidence intervals that overlap zero means that a 
type II error (the chance that the effect is present in the population but is missed in the 
sample that has been selected, in other words a false negative) has a high probability 
of occurring31 in a comparison of means.   The sample size of this study was limited 
by funding for laboratory consumables.  
 
The placebo control in the form of the sham intervention appears to be an important 
component of the present study.  Because cortisol levels changed equally after both 
the sham and cranial interventions for most participants (8 from 10 participants 
experienced either a moderate to large increase or decrease in cortisol in response to 
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both the cranial and sham interventions) it is important that a placebo is used in any 
similar future interventions.  
 
The most generalisable OCF intervention would be designed to mimic real life 
osteopathy, where the OCF practitioner has complete autonomy with techniques and 
treatment goals.   This could also introduce very low internal validity as too many 
variables would be introduced.  The reductionist experimental designs of past studies 
may have stopped the intervention from being widely generalisable and may also have 
limited treatment effect. Using a treatment goal (ie, to affect the hypothalamic-
pituitary axis in whatever way the OCF practitioner deemed appropriate, within the 
confines of OCF techniques) instead of a single technique as the guidelines for the 
OCF intervention it was hoped to increase the generalisability and chances of 
detecting a treatment effect, if there was one, at the same time as maintaining as much 
internal validity as possible.   
 
In the light of recent research published on methodological constraints this present 
study no longer has a robust scientific design.  Future studies should incorporate the 
lag in cortisol response, and control for blood glucose levels (possibly by giving a 
standardised glucose drink to each participant before exposure to the stress task).  A 
larger sample size should be used to allow for the high variability within and between 
participants salivary cortisol responses.   It may be useful to use plasma cortisol levels 
even though the sampling of blood is much more invasive, as plasma cortisol levels 
seem to exhibit less variability and may be less affected by a number of different 
variables.35   
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The ability of different stress tasks to illicit a stress response should also be 
investigated.  The Trier Social Stress Test is much utilised psychosocial stressor that 
is thought to mimic the same limbic activation and hypothalamic-pituitary axis 
activation that is associated with psychological stress.36  Or perhaps physiological 
models of stress (such as the cold pressor, or exercise) would provide a more 
consistent platform35 for evaluating change following an intervention than a 
psychological stress task. 
 
Although this study failed to find evidence to support claims that OCF can have a 
positive effect on psychological stress, further studies into the effects of OCF on 
stress are warranted before conclusive evidence based decisions can be made into the 
efficacy of utilising OCF as a treatment modality in combating psychological stress.
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List of Figures 
 
 
 
Figure 1.  Procedural flowchart. 
Procedural flowchart displaying sampling, stress task and intervention order.  Notes:  
VAS = Visual Analouge Scale, used as participant-reported subjective stress rating, 
OCF = Osteopathy in the Cranial Field. 
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Figure 2.  Comparison of cortisol levels over time-points. 
Comparison of cortisol levels over time-points in 1:20 dilution data set.  Notes: Error 
bars represent standard deviations.  Time-points are not represented linearly for ease 
of comparison. 
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Figure 3.  Comparison of self-reported ratings of stress over time-points. 
Notes: Error bars represent standard deviations.  Time-points are not represented 
linearly for ease of comparison. 
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Figure 4.  Relationship between individual objective cortisol levels and 
subjective self-reported ratings of stress.   
Notes:  VAS = Visual Analogue Scale used to rate subjective stress. 
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Table 1.  Individual cortisol levels and self-reported stress ratings. 
 
Individual results for salivary cortisol and SRSS for all participants 
 
Subject 
Intervention 
Type Initial Pre-Intervention Post-Intervention 
Change from 
Initial to Pre-Int 
Change from 
Pre-Int to Post-
Int 
    Cortisol SRSS Cortisol  SRSS Cortisol SRSS Cortisol SRSS Cortisol   SRSS 
1 Sham 4431 30 5689 70 6324 10 1258 40 635 -60 
 F, S Cranial   10   70   20   60   -50 
2 Sham 2759 10 6129 60 6612 0 3370 50 483 -60 
 M, NS Cranial 4065 20 5915 60 8589 10 1850 40 2674 -50 
3 Sham 8172 40 10076 60 9131 10 1903 20 -944 -50 
 M, NS Cranial 7806 30 8990 70 6103 10 1184 40 -2887 -60 
4 Sham 7757 50 7536 50 5671 40 -221 0 -1865 -10 
 F, NS Cranial 7090 70 8732 80 7462 60 1641 10 -1270 -20 
5 Sham 6905 10 7065 60 5198 0 159 50 -1867 -60 
 F, NS Cranial 4493 10 4195 50 3115 0 -297 40 -1080 -50 
6 Sham 9617 40 11310 70 8862 15 1693 30 -2448 -55 
 M, S Cranial 6081 35 6355 70 6060 10 274 35 -295 -60 
7 Sham 5590 20 4641 50 4751 5 -949 30 110 -45 
 F, NS Cranial 8646 30 8726 70 6518 5 80 40 -2208 -65 
8 Sham 1312 10 2563 50 3341 20 1251 40 778 -30 
 F, NS Cranial 4245 10 3709 70 4566 0 -536 60 857 -70 
9 Sham 4201 5 4030 80 7513 5 -171 75 3484 -75 
 M, NS Cranial 5431 0 6957 60 5079 0 1526 60 -1878 -60 
10 Sham 11844 20 7877 45 6085 10 -3967 25 -1792 -35 
 M, NS Cranial 5501 25 8068 30 4611 20 2567 5 -3457 -10 
11 Sham 3973 60 6070 90 6802 50 2098 30 731 -40 
 M, NS Cranial                 
12 Sham 3705 20 3976 60 2767 0 271 40 -1208 -60 
 F, NS Cranial 4012 0 2492 60 3585 0 -1520 60 1093 -60 
Notes:  All cortisol concentration provided in pg/ml, and SRSS scores in mm.  Pre-Int = Pre-Intervention sample, Post-Int = 
Post-Intervention sample, M = Male, F = Female, S = Smoker, NS = Non Smoker.  All smokers responded positively to the 
question “have you smoked at all in the past two years”. 
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Table 2.   Individual effect sizes and self-reported stress scores. 
 
Individual Effect Sizes catalogued as positive, non- and negative responders and then 
grouped as per individual response to the cranial intervention. 
 
 
Interventio
n Type 
Effect Size 
from Initial 
to Pre-Int 
Response 
from Initial to 
Pre-Int 
SRSS 
change after 
Stress Task 
Effect Size 
from Pre-Int 
to Post-Int 
Response from 
Pre-Int to Post-
Int 
SRSS change 
after 
Intervention 
Positive Responder to Cranial Intervention 
Subject 
2 Sham 1.72 + 50 1.34 + -60 
  Cranial 1.26 + 40 1.31 + -50 
Subject 
8 Sham 1.61 + 40 1.44 + -30 
  Cranial -1.12 - 60 1.42 + -70 
Subject 
12 Sham 0.74 + 40 -1.57 - -60 
  Cranial -1.68 - 60 1.46 + -60 
Negative Responder to Cranial Intervention 
Subject 
3 Sham 0.89 + 20 -0.47 N -50 
  Cranial 1.31 + 40 -1.58 - -60 
Subject 
5 Sham 0.37 N 50 -1.64 - -60 
  Cranial -0.74 - 40 -1.29 - -50 
Subject 
7 Sham -1.63 - 30 0.54 N -45 
  Cranial 0.19 N 40 -1.72 - -65 
Subject 
9 Sham -1.2 - 75 1.49 + -75 
  Cranial 1.72 + 60 -1.69 - -60 
Subject 
10 Sham -1.69 - 25 -1.51 - -35 
  Cranial 1.61 + 5 -1.65 - -10 
Non Responder to Cranial Intervention 
Subject 
4 Sham -0.06 N 0 -0.7 - -10 
  Cranial 0.77 + 10 -0.53 N -20 
Subject 
6 Sham 1.41 + 30 -1.53 - -55 
  Cranial 1.18 + 35 -0.57 N -60 
No Results from Cranial Intervention 
Subject 
1 Sham 1.41 + 40 1.01 + -60 
  Cranial     60     -50 
Subject 
11 Sham 1.44 + 30 0.81 + -40 
  Cranial             
 
Notes:  + = positive responder (Effect Size range 0.61-2.0), N = non-responder (Effect Size range 0 - 0.60), - = negative 
responder (Effect Size range -0.61 + -2.0) 
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Appendix I 
 
Ethics approval for this project 
 
 
 
 
 
 
Jeannette Vreede 
50 Waitea Road  
Muriwai Beach  
Auckland  
 
 
 
21 August  2008   
Dear Jeannette  
 
Your file number for this application: 2008.868 
 
Title: The effects of osteopathy in the cranial field on stress as measured by 
salivary cortisol levels 
 
Your application for ethics approval has been reviewed by the Unitec Research 
Ethics Committee (UREC) and has been approved for the following period: 
 
Start date: 20 August 2008  
Finish date: 20 August 2009  
 
Please note that: 
1. the above dates must be referred to on the information AND consent forms 
given to all participants 
2. you must inform UREC, in advance, of any ethically-relevant deviation in the 
project. This may require additional approval. 
 
You may now commence your research according to the protocols approved by 
UREC. We wish you every success with your project. 
 
Yours sincerely 
 
 
Deborah Rolland 
Deputy Chair, UREC 
 
cc: Craig Hilton  
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Appendix II 
 
 
Information sheet for participants 
 
 
 
 
  
INFORMATION SHEET  
 
The effects of Osteopathy in the Cranial Field on stress as measured 
by salivary cortisol levels Information sheet 
 
About this research 
You are invited to take part in a research project being undertaken by Jeanette Vreede 
in order to complete her Masters in Osteopathy.  
This research project is investigating the role of Osteopathy in the Cranial Field 
(OCF) on stress.  Participants of the study will perform a serial addition task in order 
to slightly raise stress levels, and then will receive an OCF treatment.  Saliva will be 
collected from participants directly before the stress task, after the stress task and 
after the OCF intervention.  This will allow the researcher to measure the hormone 
cortisol that is produced by the body in response to stress. 
Osteopathy in the Cranial Field: 
Is a very gentle technique used by osteopaths, founded in the late 19th Century.  The 
practitioner cradles the patients head, and may apply very slight amounts of pressure 
to the skull.  It is not uncommon for patients to be unaware of any movements or 
pressure applied by the practitioner during the treatment. 
Serial Addition Stress Task: 
Participants will be required to listen to numbers being presented to them via a 
computer.  The first number will be added to the second number, and then the third 
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number will be added to the answer, in a serial manner.  The answers are required to 
be correct, and a short time frame is given for each addition to be completed.  Some 
people may find this task frustrating. 
Collection of Saliva: 
Participants will be asked to chew on pieces of unflavoured wax to stimulate the 
production of saliva.  They will then be asked to spit into a collection tube.  This will 
be stored in a locked freezer until they are analysed, and disposed of appropriately 
directly after analysis. 
Your involvement in this research will help Jeanette Vreede in obtaining her Masters 
degree, and will further the knowledge base on Cranial Osteopathy helping 
practitioners and public to make more informed choices about treatments for stress. 
 
The Researchers 
Jeanette Vreede, BSc, BAppSc (HB) 
This project is being supervised by Dr Craig Hilton, BSc (Hons) MSc, MFA, PhD and 
Dr Andy Stewart, BPhEd (Hons), BEd (Tchg), BSc, PhD 
Selection of Participants 
You were either recruited via posters on the Unitec, Auckland University and 
Auckland Medical School campuses or were approached by a third party (ie, not the 
researchers) after someone you knew indicated you might be interested in 
participating in this project. 
To participate you must not: 
 
1. Have had any prior cranial osteopathic treatment, or have previous 
knowledge of what a cranial treatment comprises. 
2. Be currently taking medications that will affect salivary cortisol levels. 
3. Have a history of an endocrine or neuro-endocrine disorder. 
4. Have a history of psychiatric disorders. 
5. Be deemed by the OCF practitioner to have any contraindications to 
receiving OCF. 
6. Consider yourself to have an extremely high or low stress level. 
 
You have the right to not participate, or withdraw from this research survey.  
This can be done by informing  Jeanette Vreede or Craig Hilton that you would 
no longer like to participate.  You may choose to do this at any time for up to 
TWO WEEKS AFTER DATA COLLECTION, which occurs during the 
experimental procedure.  
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Getting help 
Please feel free to contact me should you have any further questions, or require 
further information about the project. 
Jeanette Vreede 
021 2800 924 
09 411 5464 
If you want further information about the project you can write, fax or email the 
above address. 
At anytime if you are concerned about the way the project is being run or confused 
about the research project you may contact the Unitec on 09 815 4321 ext 8601 and 
speak to Craig Hilton, Principal Supervisor and Course Co-Ordinator for the Research 
Component of  the MOst. 
 
Confidentiality 
Confidentiality and your anonymity will be protected in the following ways: 
• All subjects will be assigned a number at the beginning of the experimental 
procedure.  Any reference to individual subjects during the procedure will be 
made via these numbers.  No names will be used during the write up of the 
research project. 
• This will mean that your name is only ever recorded on your consent form. 
• The practitioner involved in this research will only be given the number assigned 
to you, and will sit behind a curtain to treat you; thereby your identity will be 
blinded to them also. 
 
A copy of the final report will be available from Jeanette Vreede.  All participants are 
welcome to view this.  
Finally, we would like to thank you for your valuable contribution to this research.  
 
Thank You. 
 
This study has been approved by the UNITEC Research Ethics Committee from 
20.05.2008  to 20.05.2009.  If you have any complaints or reservations about the 
ethical conduct of this research, you may contact the Committee through the Secretary  
(ph: 09 815-4321 ext 8041).  Any issues you raise will be treated in confidence and 
investigated fully, and you will be informed of the outcome. 
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Appendix III 
Consent form for participants 
 
 
 
 
 
  
The effects of Osteopathy in the Cranial Field on stress as measured by salivary 
cortisol levels.   
 
Consent Form  
This research project is investigating the role of Osteopathy in the Cranial Field 
(OCF) on 
stress.  Participants will perform a serial addition task in order to slightly raise stress 
levels, and then will receive an OCF treatment.  Saliva will be collected from 
participants directly before the stress task, after the stress task and after the OCF 
intervention.  This will allow the researcher to measure the hormone cortisol that is 
produced by the body in response to stress. 
The research is being done by Jeanette Vreede from UNITEC Institute of Technology, 
and will be supervised by Craig Hilton and Andy Stewart. 
 
Name of Participant:…………………………………………………………………. 
 
I have seen the Information Sheet dated________ for people taking part in the 
research project “The effects of Osteopathy in the Cranial Field on stress as measured 
by salivary cortisol levels”. I have had the opportunity to read the contents of the 
information sheet and to discuss the project with the above researcher or supervisors 
and I am satisfied with the explanations I have been given.  I understand that taking 
part in this project is voluntary (my choice) and that I may withdraw from the project 
at any time up to two weeks after data collection. 
 
I understand that I can withdraw from the Osteopathic in the Cranial Field 
treatment or any other part of the research project if, for any reason, I want this, 
up to two weeks after data collection has occurred. 
 
I understand that my participation in this project is confidential and that no 
material that could identify me will be used in any reports on this project. 
 
I have had enough time to consider whether I want to take part. 
 
I know whom to contact if I have any questions or concerns about the project. 
 
The principal researcher for this project is:  
 
Jeanette Vreede,  
50 Waitea Rd, Muriwai Beach 
Phone:  09 411 5464 
102 
jeanieus@gmail.com 
 
 
 
 
Signature……………………………………………………….participant   
……….(date) 
 
Project explained by…………………………………………… 
 
Signature……………………………………………………….               
…………...(date) 
 
The participant should retain a copy of this consent form. 
 
This study has been approved by the UNITEC Research Ethics Committee from (date) to (date).  If you 
have any complaints or reservations about the ethical conduct of this research, you may contact the 
Committee through the Secretary (ph: 09 815-4321 ext 8041).  Any issues you raise will be treated in 
confidence and investigated fully, and you will be informed of the outcome. 
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Appendix IV 
 
Visual Analouge Scale utilised in this project 
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Appendix V 
Raw Data and Transformation Calculations 
 
KC Junior Data for Plate One 
 
Template Plate One 
BLK 
STD
01 
STD
01 
1.2.1 
1:20 
1.2.1 
1:20 
2.1.2 
1:20 
2.1.2 
1:20 
2.2.3 
1:20 
2.2.3 
1:20 
3.2.1 
1:20 
3.2.1 
1:20 
4.1.2 
1:20 
BLK 
STD
02 
STD
02 
1.2.1 
1:80 
1.2.1 
1:80 
2.1.2 
1:80 
2.1.2 
1:80 
2.2.3 
1:80 
2.2.3 
1:80 
3.2.1 
1:80 
3.2.1 
1:80 
4.1.2 
1:80 
CTL
1 
STD
03 
STD
03 
1.2.2 
1:20 
1.2.2 
1:20 
2.1.3 
1:20 
2.1.3 
1:20 
3.1.1 
1:20 
3.1.1 
1:20 
3.2.2 
1:20 
3.2.2 
1:20 
4.1.3 
1:20 
CTL
1 
STD
04 
STD
04 
1.2.2 
1:80 
1.2.2 
1:80 
2.1.3 
1:80 
2.1.3 
1:80 
3.1.1 
1:80 
3.1.1 
1:80 
3.2.2 
1:80 
3.2.2 
1:80 
4.1.3 
1:80 
CTL
2 
STD
05 
STD
05 
1.2.3 
1:20 
1.2.3 
1:20 
2.2.2 
1.20 
2.2.2 
1.20 
3.1.2 
1:20 
3.1.2 
1:20 
3.2.3 
1:20 
3.2.3 
1:20 
4.2.1 
1:80 
CTL
2 
STD
06 
STD
06 
1.2.3 
1:80 
1.2.3 
1:80 
2.2.1 
1:80 
2.2.1 
1:80 
3.1.2 
1:80 
3.1.2 
1:80 
3.2.3 
1:80 
3.2.3 
1:80 
4.2.1 
1:20 
CTL
2 
STD
07 
STD
07 
2.1.1 
1:20 
2.1.1 
1:20 
2.2.1 
1:20 
2.2.1 
1:20 
3.1.3 
1:20 
3.1.3 
1:20 
4.1.1 
1:20 
4.1.1 
1:20 
4.2.2 
1:20 
CTL
3 
STD
08 
STD
08 
2.1.1 
1:80 
2.1.1 
1:80 
2.2.2 
1:80 
2.2.2 
1:80 
3.1.3 
1:80 
3.1.3 
1:80 
4.1.1 
1:80 
4.1.1 
1:80 
4.2.2 
1:80 
 
Plate: 1     
Date Created: 23/12/2009  
11:42:45 a.m.  
Raw Data                      
0.173 0.394 0.387 0.649 0.627 0.558 0.574 0.547 0.536 0.486 0.521 0.538 
0.171 0.518 0.503 0.96 0.952 0.86 0.87 0.856 0.808 0.782 0.85 0.841 
0.171 0.611 0.595 0.602 0.552 0.531 0.469 0.505 0.514 0.45 0.505 0.582 
0.174 0.748 0.766 0.896 0.87 0.828 0.787 0.786 0.804 0.718 0.756 0.923 
1.431 0.901 0.872 0.557 0.545 0.566 0.55 0.499 0.476 0.468 0.506 0.875 
1.45 1.094 1.048 0.8 0.84 0.505 0.496 0.749 0.74 0.765 0.827 0.629 
1.348 1.149 0.515 0.593 0.753 0.78 0.743 0.582 0.539 0.499 0.567 0.628 
3 0.852 0.839 0.796 0.855 0.8 0.829 0.837 0.799 0.753 0.84 0.914 
 
Blanked Data 
0.001 0.222 0.215 0.477 0.455 0.386 0.402 0.375 0.364 0.314 0.349 0.366 
-
0.001 0.346 0.331 0.788 0.78 0.688 0.698 0.684 0.636 0.61 0.678 0.669 
-
0.001 0.439 0.423 0.43 0.38 0.359 0.297 0.333 0.342 0.278 0.333 0.41 
0.002 0.576 0.594 0.724 0.698 0.656 0.615 0.614 0.632 0.546 0.584 0.751 
1.259 0.729 0.7 0.385 0.373 0.394 0.378 0.327 0.304 0.296 0.334 0.703 
1.278 0.922 0.876 0.628 0.668 0.333 0.324 0.577 0.568 0.593 0.655 0.457 
1.176 0.977 0.343 0.421 0.581 0.608 0.571 0.41 0.367 0.327 0.395 0.456 
105 
2.828 0.68 0.667 0.624 0.683 0.628 0.657 0.665 0.627 0.581 0.668 0.742 
 
Transformation Results Plate One – equation used (((X-0.1720)-0.0005)/1.2372)x100 
0.001 17.9 17.34 38.51 36.74 31.16 32.45 30.27 29.38 25.34 28.17 29.54 
-
0.001 27.93 26.71 63.65 63.01 55.57 56.38 55.25 51.37 49.26 54.76 54.03 
-
0.001 35.44 34.15 34.72 30.67 28.98 23.97 26.88 27.6 22.43 26.88 33.1 
0.002 46.52 47.97 58.48 56.38 52.98 49.67 49.59 51.04 44.09 47.16 60.66 
1.259 58.88 56.54 31.08 30.11 31.81 30.51 26.39 24.53 23.88 26.96 56.78 
1.278 74.48 70.76 50.72 53.95 26.88 26.15 46.6 45.87 47.89 52.9 36.9 
1.176 78.93 27.68 33.99 46.92 49.1 46.11 33.1 29.62 26.39 31.89 36.82 
2.828 54.92 53.87 50.4 55.16 50.72 53.06 53.71 50.64 46.92 53.95 59.93 
 
Concentrations / Dilutions Plate One 
 1000 1000 20 20 20 20 20 20 20 20 20 
 500 500 80 80 80 80 80 80 80 80 80 
1 250 250 20 20 20 20 20 20 20 20 20 
1 125 125 80 80 80 80 80 80 80 80 80 
1 62.5 62.5 20 20 20 20 20 20 20 20 80 
1 31.3 31.3 80 80 80 80 80 80 80 80 20 
1 15.6 15.6 20 20 20 20 20 20 20 20 20 
1 7.8 7.8 80 80 80 80 80 80 80 80 80 
 
Calculated Concentrations Plate One 
???? ???? ???? 4246 4615 6122 5708 6438 6786 9020 7325 6720 
???? 372.1 405 ???? ???? 6627 6161 6810 8942 
1009
4 7082 7485 
???? 245.5 261.6 5088 6290 6956 
1022
1 8006 7607 
1214
5 8006 5519 
???? 145.6 135.2 4872 6161 8062 9871 9916 9118 
1310
7 
1127
7 3270 
???? 57.54 75.83 6149 6498 5909 6349 8298 9683 
1030
4 7959 5924 
???? ???? ???? 9295 7530 
3202
3 
3381
0 
1160
3 
1203
0 
1086
3 8106 4580 
???? ???? 378.3 5275 2854 2546 2972 5519 6687 8298 5883 4598 
???? 87.39 94.68 9472 6855 9295 8018 7663 9339 
1141
6 7530 3854 
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KC Junior Data for Plate Two 
 
Template Plate Two 
4.2.3 
1:20 
4.2.3 
1:20 
5.2.1 
1:20 
5.2.1 
1:20 
6.1.2 
1:20 
6.1.2 
1:20 
6.2.3 
1:20 
6.2.3 
1:20 
7.2.1 
1:20 
7.2.1 
1:20 
8.1.2 
1:20 
8.1.2 
1:20 
4.2.3 
1:80 
4.2.3 
1:80 
5.2.1 
1:80 
5.2.1 
1:80 
6.1.2 
1:80 
6.1.2 
1:80 
6.2.3 
1:80 
6.2.3 
1:80 
7.2.1 
1:80 
7.2.1 
1:80 
8.1.2 
1:80 
8.1.2 
1:80 
5.1.1 
1:20 
5.1.1 
1:20 
5.2.2 
1:20 
5.2.2 
1:20 
6.1.3 
1:20 
6.1.3 
1:20 
7.1.1 
1:20 
7.1.1 
1:20 
7.2.2 
1:20 
7.2.2 
1:20 
8.1.3 
1:20 
8.1.3 
1:20 
5.1.1 
1:80 
5.1.1 
1:80 
5.2.2 
1:80 
5.2.2 
1:80 
6.1.3 
1:80 
6.1.3 
1:80 
7.1.1 
1:80 
7.1.1 
1:80 
7.2.2 
1:80 
7.2.2 
1:80 
8.1.3 
1:80 
8.1.3 
1:80 
5.1.2 
1:20 
5.1.2 
1:20 
5.2.3 
1:20 
5.2.3 
1:20 
6.2.1 
1:20 
6.2.1 
1:20 
7.1.2 
1:20 
7.1.2 
1:20 
7.2.3 
1:20 
7.2.3 
1:20 
8.2.1 
1:20 
8.2.1 
1:20 
5.1.2 
1:80 
5.1.2 
1:80 
5.2.3 
1:80 
5.2.3 
1:80 
6.2.1 
1:80 
6.2.1 
1:80 
7.1.2 
1:80 
7.1.2 
1:80 
7.2.3 
1:80 
7.2.3 
1:80 
8.2.1 
1:80 
8.2.1 
1:80 
5.1.3 
1:20 
5.1.3 
1:20 
6.1.1 
1:20 
6.1.1 
1:20 
6.2.2 
1:20 
6.2.2 
1:20 
7.1.3 
1:20 
7.1.3 
1:20 
8.1.1 
1:20 
8.1.1 
1:20 
8.2.2 
1:20 
8.2.2 
1:20 
5.1.3 
1:80 
5.1.3 
1:80 
6.1.1 
1:80 
6.1.1 
1:80 
6.2.2 
1:80 
6.2.2 
1:80 
7.1.3 
1:80 
7.1.3 
1:80 
8.1.1 
1:80 
8.1.1 
1:80 
8.2.2 
1:80 
8.2.2 
1:80 
 
Plate: 2 
Date Created: 23/12/2009  
11:50:36 a.m. 
Raw Data           
0.56 0.593 0.548 0.519 0.543 0.557 0.482 0.496 0.502 0.484 0.787 0.77 
0.83 0.877 0.863 0.83 0.834 0.84 0.774 0.772 0.768 0.728 1.039 1.049 
0.621 0.648 0.531 0.525 0.583 0.541 0.576 0.582 0.49 0.492 0.742 0.686 
0.912 0.985 0.842 0.771 0.853 0.866 0.886 0.874 0.746 0.756 1.04 0.969 
0.629 0.678 0.619 0.577 0.474 0.48 0.639 0.613 0.55 0.539 0.676 0.625 
0.917 0.981 0.92 0.904 0.709 0.705 0.841 0.853 0.848 0.801 1.018 0.922 
0.687 0.78 0.561 0.558 0.45 0.466 0.616 0.623 0.913 0.861 0.672 0.699 
0.793 0.937 0.833 0.855 0.652 0.699 0.843 0.733 1.128 1.131 0.977 0.979 
 
Transformation Results Plate Two - equation used (((X-0.1720)-0.0005)/1.2372)x100 
31.32 33.99 30.35 28.01 29.95 31.08 25.02 26.15 26.63 25.18 49.67 48.29 
53.14 56.94 55.81 53.14 53.47 53.95 48.62 48.46 48.13 44.9 70.04 70.85 
36.25 38.43 28.98 28.49 33.18 29.78 32.61 33.1 25.66 25.82 46.03 41.51 
59.77 65.67 54.11 48.38 55 56.05 57.67 56.7 46.35 47.16 70.12 64.38 
36.9 40.86 36.09 32.69 24.37 24.85 37.71 35.6 30.51 29.62 40.7 36.57 
60.18 65.35 60.42 59.13 43.36 43.04 54.03 55 54.6 50.8 68.34 60.58 
41.59 49.1 31.4 31.16 22.43 23.72 35.85 36.41 59.85 55.65 40.37 42.56 
50.15 61.79 53.39 55.16 38.76 42.56 54.19 45.3 77.23 77.47 65.03 65.19 
 
Concentrations / Dilutions Plate Two 
20 20 20 20 20 20 20 20 20 20 20 20 
80 80 80 80 80 80 80 80 80 80 80 80 
20 20 20 20 20 20 20 20 20 20 20 20 
80 80 80 80 80 80 80 80 80 80 80 80 
20 20 20 20 20 20 20 20 20 20 20 20 
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80 80 80 80 80 80 80 80 80 80 80 80 
20 20 20 20 20 20 20 20 20 20 20 20 
80 80 80 80 80 80 80 80 80 80 80 80 
 
Calculated Concentrations Plate Two 
6067 5275 6408 7403 6560 6149 9272 8453 8149 9144 2468 2659 
7973 5827 6488 7973 7796 7530 10454 10544 10726 12610 ???? ???? 
4723 4262 6956 7173 5496 6623 5660 5519 8783 8670 2984 3698 
3975 ???? 7441 10590 6946 6349 5385 5971 11745 11277 ???? ???? 
4580 3810 4760 5636 9830 9404 4409 4872 6349 6687 3839 4651 
3667 ???? 3473 4438 13565 13773 7485 6946 7172 9251 ???? 3339 
3684 2546 6040 6122 12145 10474 4815 4687 978.7 1645 3897 3522 
9604 2146 7841 6855 16795 14088 7396 12367 ???? ???? ???? ???? 
 
KC Junior Data for Plate 3  
 
Template 
SMP
01 
SMP
01 
SMP
09 
SMP
09 
SMP
17 
SMP
17 
SMP
25 
SMP
25 
SMP
33 
SMP
33 
SMP
41 
SMP
41 
SMP
02 
SMP
02 
SMP
10 
SMP
10 
SMP
18 
SMP
18 
SMP
26 
SMP
26 
SMP
34 
SMP
34 
SMP
42 
SMP
42 
SMP
03 
SMP
03 
SMP
11 
SMP
11 
SMP
19 
SMP
19 
SMP
27 
SMP
27 
SMP
35 
SMP
35 
SMP
43 
SMP
43 
SMP
04 
SMP
04 
SMP
12 
SMP
12 
SMP
20 
SMP
20 
SMP
28 
SMP
28 
SMP
36 
SMP
36 
SMP
44 
SMP
44 
SMP
05 
SMP
05 
SMP
13 
SMP
13 
SMP
21 
SMP
21 
SMP
29 
SMP
29 
SMP
37 
SMP
37 
SMP
45 
SMP
45 
SMP
06 
SMP
06 
SMP
14 
SMP
14 
SMP
22 
SMP
22 
SMP
30 
SMP
30 
SMP
38 
SMP
38 
SMP
46 
SMP
46 
SMP
07 
SMP
07 
SMP
15 
SMP
15 
SMP
23 
SMP
23 
SMP
31 
SMP
31 
SMP
39 
SMP
39 
SMP
47 
SMP
47 
SMP
08 
SMP
08 
SMP
16 
SMP
16 
SMP
24 
SMP
24 
SMP
32 
SMP
32 
SMP
40 
SMP
40 
SMP
48 
SMP
48 
 
Plate: 3 
Date Created: 23/12/2009 
11:52:53 a.m. 
Raw Data           
0.653 0.609 0.592 0.58 0.523 0.495 0.673 0.59 0.689 0.682 0.803 0.767 
0.899 0.876 0.863 0.869 0.775 0.744 0.904 0.851 0.946 0.854 1.04 0.99 
0.66 0.644 0.533 0.529 0.573 0.547 0.693 0.643 0.695 0.641 0.729 0.663 
0.828 0.841 0.765 0.774 0.775 0.734 0.874 0.818 0.929 0.917 0.986 0.899 
0.664 0.662 0.617 0.589 0.614 0.557 0.599 0.53 0.756 0.765 0.463 0.619 
0.849 0.874 0.88 0.843 0.854 0.784 0.766 0.737 0.959 1.062 0.48 0.674 
0.487 0.56 0.454 0.451 0.511 0.497 0.546 0.526 0.652 0.677 0.461 0.623 
0.62 0.623 0.669 0.581 0.731 0.736 0.767 0.657 0.876 0.883 0.466 0.667 
 
108 
 
Transformation Results Plate 3 - equation used (((X-0.1720)-0.0005)/1.2372)x100 
38.84 35.28 33.91 32.94 28.33 26.07 40.45 33.75 41.75 41.18 50.96 48.05 
58.72 56.86 55.81 56.3 48.7 46.19 59.13 54.84 62.52 55.08 70.12 66.08 
39.4 38.11 29.14 28.82 32.37 30.27 42.07 38.03 42.23 37.87 44.98 39.65 
52.98 54.03 47.89 48.62 48.7 45.38 56.7 52.17 61.15 60.18 65.75 58.72 
39.73 39.57 35.93 33.66 35.69 31.08 34.47 28.9 47.16 47.89 23.48 36.09 
54.68 56.7 57.19 54.19 55.08 49.43 47.97 45.63 63.57 71.9 24.85 40.54 
25.42 31.32 22.75 22.51 27.36 26.23 30.19 28.57 38.76 40.78 23.32 36.41 
36.17 36.41 40.13 33.02 45.14 45.55 48.05 39.16 56.86 57.43 23.72 39.97 
 
Concentrations / Dilutions Plate 3 
20 20 20 20 20 20 20 20 20 20 20 20 
80 80 80 80 80 80 80 80 80 80 80 80 
20 20 20 20 20 20 20 20 20 20 20 20 
80 80 80 80 80 80 80 80 80 80 80 80 
20 20 20 20 20 20 20 20 20 20 20 80 
80 80 80 80 80 80 80 80 80 80 20 80 
20 20 20 20 20 20 20 20 20 20 20 80 
80 80 80 80 80 80 80 80 80 80 20 80 
 
Calculated Concentrations 
4183 4949 5297 5566 7248 8506 3882 5340 3657 3754 2291 2693 
4712 5876 6488 6208 10409 11839 4438 7037 ???? 6901 ???? ???? 
4075 4327 6887 7027 5733 6438 3602 4343 3575 4376 3140 4030 
8062 7485 10863 10454 10409 12318 5971 8502 2833 3667 ???? 4712 
4015 4045 4797 5362 4853 6149 5149 6992 2819 2716 10744 19039 
7127 5971 5682 7396 6901 10005 10817 12173 ???? ???? 9404 15470 
8959 6067 11667 12021 7735 8400 6468 7136 4199 3825 10933 18747 
18965 18747 15761 22169 12464 12222 10771 16484 5876 5535 10474 15879 
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Appendix VI 
 
Standard curve 
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Appendix VII 
Raw Data – Cortisol Concentrations 
  
Conc. as 
read at 
1:20 
dilution 
(pg/ml) 
Average 
conc 
1:20 dil. 
(pg/ml) 
St. Dev. 
conc of 
1:20 dil. 
Conc. as 
read at  
1:80 
dilution 
(pg/ml) 
Average 
conc 1:80 
dil. 
(pg/ml) 
St. Dev. 
conc of 
1:80 dil. 
Final 
average 
(pg/ml) 
St Dev. 
of final 
average 
Subject 1 
                
Sham 
                
Pre Stress 4246.35     ??????         
  4615.37 4430.86 260.94 ?????? #DIV/0! #DIV/0! 4430.86 260.94 
Post Stress 5087.91     4871.64         
  6290.34 5689.13 850.25 6161.30 5516.47 911.93 5602.80 726.71 
Post Int 6149.08     9294.78         
  6498.43 6323.75 247.03 7530.02 8412.40 1247.87 7368.08 1411.93 
Cranial 
                
Pre Stress                 
                  
Post Stress                 
                  
Post Int                 
                  
Subject 2 
                
Sham 
                
Pre Stress 2545.96     32022.79         
  2971.67 2758.82 301.02 33810.49 32916.64 1264.09 2758.82 301.02 
Post Stress 5908.67     9294.78         
  6348.52 6128.60 311.02 8017.60 8656.19 903.10 7392.39 1560.03 
Post Int 6437.68     6809.82         
  6785.85 6611.76 246.19 8942.17 7875.99 1507.80 7243.88 1144.89 
Cranial 
                
Pre Stress 5275.28     9471.56         
  2854.09 4064.68 1712.04 6855.37 8163.46 1849.93 6114.07 2778.09 
Post Stress 6121.52     6626.69         
  5708.38 5914.95 292.13 6161.30 6394.00 329.08 6154.47 375.56 
Post Int 6956.42     8061.75         
  10220.92 8588.67 2308.35 9871.03 8966.39 1279.36 8777.53 1539.25 
Subject 3 
                
Sham 
                
Pre Stress 9019.84     10094.26         
  7324.58 8172.21 1198.74 7081.92 8588.09 2130.04 8380.15 1431.43 
Post Stress 12145.32     13107.16         
  8005.70 10075.51 2927.16 11276.91 12192.03 1294.18 11133.77 2215.31 
Post Int 10303.74     10862.67         
  7959.19 9131.47 1657.85 8105.86 9484.27 1949.36 9307.87 1491.41 
Cranial 
                
Pre Stress 8005.70     9915.59         
111 
  7606.97 7806.33 281.94 9118.35 9516.97 563.74 8661.65 1052.55 
Post Stress 8297.65     11603.43         
  9682.92 8990.29 979.53 12029.59 11816.51 301.34 10403.40 1735.69 
Post Int 5519.24     7663.44         
  6687.37 6103.31 825.99 9338.94 8501.19 1184.76 7302.25 1616.14 
Subject 4 
                
Sham 
                
Pre Stress 4580.20     5923.63         
  10933.01 7756.61 4492.11 18747.16 12335.39 9067.61 10046.00 6412.64 
Post Stress 4597.74     3853.79         
  10474.39 7536.06 4155.41 15879.47 9866.63 8503.45 8701.35 5627.54 
Post Int 6067.04     7973.44         
  5275.28 5671.16 559.86 5827.45 6900.44 1517.45 6285.80 1172.92 
Cranial 
                
Pre Stress 8297.65     11416.35         
  5882.98 7090.32 1707.43 7530.02 9473.19 2748.05 8281.75 2319.85 
Post Stress 6719.88     7485.46         
  10743.74 8731.81 2845.29 19038.79 13262.12 8169.44 10996.97 5637.94 
Post Int 5519.24     3269.99         
  9404.40 7461.82 2747.22 15470.21 9370.10 8626.86 8415.96 5342.02 
Subject 5 
                
Sham 
                
Pre Stress 6407.70     6488.30         
  7403.02 6905.36 703.80 7973.44 7230.87 1050.15 7068.11 753.68 
Post Stress 6956.42     7440.85         
  7172.69 7064.55 152.92 10589.58 9015.21 2226.49 8039.88 1711.31 
Post Int 4759.70     3472.51         
  5636.21 5197.95 619.79 4437.55 3955.03 682.39 4576.49 893.43 
Cranial 
                
Pre Stress 4723.05     3975.07         
  4262.33 4492.69 325.78 ?????? 3975.07 #DIV/0! 4233.88 377.33 
Post Stress 4580.20     3666.70         
  3810.26 4195.23 544.43 ?????? 3666.70 #DIV/0! 3930.96 491.24 
Post Int 3684.28     9604.42         
  2545.96 3115.12 804.91 2145.63 5875.03 5274.16 4495.07 3468.03 
Subject 6 
                
Sham 
                
Pre Stress 9829.65     13565.30         
  9404.40 9617.02 300.69 13772.62 13668.96 146.59 11642.99 2347.35 
Post Stress 12145.32     16795.28         
  10474.39 11309.85 1181.53 14088.16 15441.72 1914.22 13375.79 2716.16 
Post Int 9272.04     10453.85         
  8452.62 8862.33 579.42 10544.28 10499.06 63.94 9680.70 1003.11 
Cranial 
                
Pre Stress 6040.13     7840.78         
  6121.52 6080.82 57.55 6855.37 7348.07 696.79 6714.45 835.61 
Post Stress 6560.27     7796.49         
  6149.08 6354.67 290.75 7530.02 7663.26 188.43 7008.97 781.54 
Post Int 5496.33     6946.23         
  6623.24 6059.78 796.85 6348.90 6647.56 422.37 6353.67 621.52 
Subject 7 
                
Sham 
                
Pre Stress 5660.09     5385.35         
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  5519.24 5589.67 99.60 5971.47 5678.41 414.45 5634.04 251.37 
Post Stress 4409.39     7485.46         
  4872.01 4640.70 327.12 6946.23 7215.84 381.30 5928.27 1514.79 
Post Int 4815.40     7396.19         
  4686.79 4751.09 90.94 12366.54 7396.19 #DIV/0! 6073.64 3590.74 
Cranial 
                
Pre Stress 8148.82     10725.84         
  9143.93 8646.38 703.65 12610.46 11668.15 1332.63 10157.26 1949.54 
Post Stress 8782.87     11744.65         
  8669.60 8726.23 80.09 11276.91 11510.78 330.74 10118.51 1619.62 
Post Int 6348.52     7172.03         
  6687.37 6517.94 239.60 9250.64 8211.33 1469.80 7364.64 1301.96 
Subject 8 
                
Sham 
                
Pre Stress 978.69     ??????         
  1645.17 1311.93 471.27 ?????? #DIV/0! #DIV/0! 1311.93 471.27 
Post Stress 2467.76     ??????         
  2658.73 2563.25 135.04 ?????? #DIV/0! #DIV/0! 2563.25 135.04 
Post Int 2983.56     ??????         
  3698.08 3340.82 505.25 ?????? #DIV/0! #DIV/0! 3340.82 505.25 
Cranial 
                
Pre Stress 3838.80     ??????         
  4650.90 4244.85 574.24 3338.51 3338.51 #DIV/0! 3791.68 662.34 
Post Stress 3896.51     ??????         
  3522.04 3709.28 264.79 ?????? #DIV/0! #DIV/0! 3709.28 264.79 
Post Int 4183.11     4711.65         
  4948.96 4566.03 541.53 5875.62 5293.64 823.05 4929.84 707.12 
Subject 9 
                
Sham 
                
Pre Stress 4074.98     8061.75         
  4326.95 4200.97 178.17 7485.46 7773.60 407.50 5987.29 2078.58 
Post Stress 4014.56     7127.01         
  4044.65 4029.61 21.28 5971.47 6549.24 817.09 5289.42 1529.34 
Post Int 8959.24     18965.31         
  6067.04 7513.14 2045.09 18747.16 18856.24 154.25 13184.69 6655.12 
Cranial 
                
Pre Stress 5296.75     6488.30         
  5565.55 5431.15 190.07 6208.40 6348.35 197.92 5889.75 552.74 
Post Stress 6887.19     10862.67         
  7027.04 6957.11 98.89 10453.85 10658.26 289.08 8807.69 2144.13 
Post Int 4796.73     5681.86         
  5361.98 5079.36 399.69 7396.19 6539.02 1212.21 5809.19 1119.50 
Subject 10 
                
Sham 
                
Pre Stress 11666.73     15761.44         
  12021.03 11843.88 250.53 22169.26 18965.35 4531.02 15404.61 4875.39 
Post Stress 7247.82     10408.72         
  8505.72 7876.77 889.47 11839.25 11123.98 1011.54 9500.38 2029.68 
Post Int 5732.78     10408.72         
  6437.68 6085.23 498.44 12318.09 11363.41 1350.13 8724.32 3158.61 
Cranial 
                
Pre Stress 4853.03     6900.84         
  6149.08 5501.06 916.44 10004.84 8452.84 2194.86 6976.95 2188.63 
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Post Stress 7735.10     12463.77         
  8400.26 8067.68 470.33 12221.51 12342.64 171.31 10205.16 2485.01 
Post Int 3882.01     4437.55         
  5340.10 4611.05 1031.03 7036.76 5737.16 1837.92 5174.11 1379.50 
Subject 11 
                
Sham 
                
Pre Stress 3602.38     5971.47         
  4343.29 3972.84 523.90 8502.22 7236.85 1789.51 5604.84 2170.30 
Post Stress 5149.23     10817.00         
  6991.55 6070.39 1302.72 12173.37 11495.19 959.10 8782.79 3268.30 
Post Int 6467.92     10771.39         
  7135.71 6801.81 472.20 16483.76 13627.57 4039.26 10214.69 4587.29 
Cranial 
                
Pre Stress                 
                  
Post Stress                 
                  
Post Int                 
                  
Subject 12 
                
Sham 
                
Pre Stress 3656.80     ??????         
  3753.79 3705.29 68.58 6900.84 6900.84 #DIV/0! 5303.07 1845.59 
Post Stress 3575.43     2832.80         
  4376.19 3975.81 566.22 3666.70 3249.75 589.65 3612.78 631.26 
Post Int 2819.23     ??????         
  2715.67 2767.45 73.23 ?????? #DIV/0! #DIV/0! 2767.45 73.23 
Cranial 
                
Pre Stress 4198.82     5875.62         
  3824.51 4011.66 264.68 5534.55 5705.09 241.17 4858.37 999.32 
Post Stress 2290.61     ??????         
  2692.85 2491.73 284.43 ?????? #DIV/0! #DIV/0! 2491.73 284.43 
Post Int 3140.36     ??????         
  4029.58 3584.97 628.77 4711.65 4711.65 #DIV/0! 4148.31 787.92 
Legend:  Average 
  
Suspected laboratory error values well outside reported ranges of cortisol – not 
included in final averages 
  Known laboratory error – not included in final averages 
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Appendix VIII 
 
Graph of ANOVA of Timepoints by Treatments with 1:20 and 1:80 dilution data 
combined 
1:20 and 1:80 combined ANOVA
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Appendix IX 
 
Re-analysis of change in VAS and Cortisol data from Initial levels 
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Appendix X 
 
Magnitude of effect size from adapted from Hopkins 31 
 
Effect Size Description 
0 - 0.19 Trivial effect size 
0.2 - 0.59 Small effect size 
0.6 - 1.19 Moderate effect size 
1.2 - 1.99 Large effect size 
2.0 - 3.99 Very large effect size 
4.0 - ∞ Nearly perfect effect size 
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Appendix XI 
 
In order to provide a visual measure of variability within the effect sizes the 
individuals cortisol concentrations with standard deviations (generated from the 
reduction of raw data to a specific cortisol concentration) have been placed in a graph 
next to effect size graphs in appendix (XI). 
 
Individual Cortisol Concentrations and Effect Sizes 
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Comparison of Sham Intervention with Cranial Intervention for Subject Two
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Comparison of Sham Intervention with Cranial Intervention for Subject Three
8172.21
10075.51
9131.47
7806.33
8990.29
6103.31
0
2000
4000
6000
8000
10000
12000
14000
Pre Stress (Time 0) Post Stress (Time 0 + 6mins) Post Intervention (Time 0 + 26mins)
Time line
Co
rt
is
o
l C
o
n
ce
n
tr
at
io
n
 
(p
g/
m
l)
Sham Intervention
Cranial Intervention
Effect Size of Stress Task and Intervention Type for Subject Three
-2.00
-1.50
-1.00
-0.50
0.00
0.50
1.00
1.50
2.00
Stress Task Intervention Type
Type of Stimulus
Ef
fe
ct
 
Si
ze
Sham Intervention
Cranial Intervention
 
118 
Comparison of Sham Intervention with Cranial Intervention for Subject Four
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Comparison of Sham Intervention with Cranial Intervention for Subject Five
6905.36 7064.55
5197.95
4492.69 4195.23
3115.12
0
2000
4000
6000
8000
10000
12000
14000
Pre Stress (Time 0) Post Stress (Time 0 + 6mins) Post Intervention (Time 0 + 26mins)
Time line
Co
rt
is
o
l C
o
n
ce
n
tr
at
io
n
 
(p
g/
m
l)
Sham Intervention
Canial Intervention
Effect Size of Stress Task and Intervention Type for Subject Five
-2.00
-1.50
-1.00
-0.50
0.00
0.50
1.00
1.50
2.00
Stress Task Intervention Type
Type of Stimulus
Ef
fe
ct
 
Si
ze
Sham Intervention
Cranial Intervention
 
Comparison of Sham Intervention with Cranial Intervention for Subject Six
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Comparison of Sham Intervention with Cranial Intervention for Subject Seven
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Comparison of Sham Intervention with Cranial Intervention for Subject Eight
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Comparison of Sham Intervention with Cranial Intervention for Subject Nine
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Comparison of Sham Intervention with Cranial Intervention for Subject Ten
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Comparison of Sham Intervention with Cranial Invevention for Subject Eleven
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Comparison of Sham Intervention with Cranial Intervention for Subject Twelve
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Appendix XII 
 
IJOM Guideline for Authors  
 
 
Online Submission  
 
Submission to this journal proceeds totally online.(  http://ees.elsevier.com/ijom) 
you will be guided stepwise through the creation and uploading of the various files. 
The system automatically converts source files to a single Adobe Acrobat PDF 
version of the article, which is used in the peer-review process. Please note that even 
though manuscript source files are converted to PDF at submission for the review 
process, these source files are needed for further processing after acceptance. All 
correspondence, including notification of the Editor's decision and requests for 
revision, takes place by e-mail and via the Author's homepage, removing the need for 
a hard-copy paper trail. 
 
The above represents a very brief outline of this form of submission. It can be 
advantageous to print this "Guide for Authors" section from the site for reference in 
the subsequent stages of article preparation. 
 
Submission of an article implies that the work described has not been published 
previously (except in the form of an abstract or as part of a published lecture or 
academic thesis), that it is not under consideration for publication elsewhere, that its 
publication is approved by all authors and tacitly or explicitly by the responsible 
authorities where the work was carried out, and that, if accepted, it will not be 
published elsewhere in the same form, in English or in any other language, without 
the written consent of the Publisher. 
 
Types of contributions  
Letters to the Editor as is common in biomedical journals the editorial board 
welcomes critical response to any aspect of the journal. In particular, letters that point 
out deficiencies and that add to, or further clarify points made in a recently published 
work, are welcomed. The Editorial Board reserves the right to offer authors of papers 
the right of rebuttal, which may be published alongside the letter. 
 
Reviews and Original Articles These should be either i) reports of new findings 
related to osteopathic medicine that are supported by research evidence. These should 
be original, previously unpublished works. The report will normally be divided into 
the following sections: abstract, introduction, materials and methods, results, 
discussion, conclusion, references. Or ii) critical or systematic review that seeks to 
summarise or draw conclusions from the established literature on a topic relevant to 
osteopathic medicine. 
 
Short review The drawing together of present knowledge in a subject area, in order to 
provide a background for the reader not currently versed in the literature of a 
particular topic. Shorter in length than and not intended to be as comprehensive as 
that of the literature review paper. With more emphasis on outlining areas of deficit in 
the current literature that warrant further investigation. 
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Research Note Findings of interest arising from a larger study but not the primary aim 
of the research endeavour, for example short experiments aimed at establishing the 
reliability of new equipment used in the primary experiment or other incidental 
findings of interest, arising from, but not the topic of the primary research. Including 
further clarification of an experimental protocol after addition of further controls, or 
statistical reassessment of raw data. 
 
Preliminary Findings Presentation of results from pilot studies which may establish a 
solid basis for further investigations. Format similar to original research report but 
with more emphasis in discussion of future studies and hypotheses arising from pilot 
study. 
 
Commentaries Include articles that do not fit into the above criteria as original 
research. Includes commentary and essays especially in regards to history, 
philosophy, professional, educational, clinical, ethical, political and legal aspects of 
osteopathic medicine. 
 
Clinical Practice Authors are encouraged to submit papers in one of the following 
formats: Case Report, Case Problem, and Evidence in Practice. 
 
Case Reports usually document the management of one patient, with an emphasis on 
presentations that are unusual, rare or where there was an unexpected response to 
treatment eg. an unexpected side effect or adverse reaction. Authors may also wish to 
present a case series where multiple occurrences of a similar phenomenon are 
documented. Preference will be given to reports that are prospective in their planning 
and utilise Single System Designs, including objective measures. 
 
The aim of the Case Problem is to provide a more thorough discussion of the 
differential diagnosis of a clinical problem. The emphasis is on the clinical reasoning 
and logic employed in the diagnostic process.  
 
The purpose of the Evidence in Practice report is to provide an account of the 
application of the recognised Evidence Based Medicine process to a real clinical 
problem. The paper should be written with reference to each of the following five 
steps: 1. Developing an answerable clinical question. 2. The processes employed in 
searching the literature for evidence. 3. The appraisal of evidence for usefulness and 
applicability. 4. Integrating the critical appraisal with existing clinical expertise and 
with the patient's unique biology, values, and circumstances. 5. Reflect on the process 
(steps 1-4), evaluating effectiveness, and identifying deficiencies. 
 
Presentation of Typescripts  
 
Your article should be typed on A4 paper, double-spaced with margins of at least 
3cm. Number all pages consecutively beginning with the title page. 
 
To facilitate anonymity, the author's names and any reference to their addresses 
should only appear on the title page. Please check your typescript carefully before you 
send it off, both for correct content and typographic errors. It is not possible to change 
the content of accepted typescripts during production. 
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Papers should be set out as follows, with each section beginning on a separate page: 
 
Title page  
To facilitate the peer-review process, two title pages are required. The first should 
carry just the title of the paper and no information that might identify the author or 
institution. The second should contain the following information: title of paper; full 
name(s) and address(es) of author(s) clearly indicating who is the corresponding 
author; you should give a maximum of four degrees/qualifications for each author and 
the current relevant appointment only; institutional affiliation; name, address, 
telephone, fax and e-mail of the corresponding author; source(s) of support in the 
form of funding and/or equipment. 
 
Keywords  
Include three to ten keywords. These should be indexing terms that may be published 
with the abstract with the aim of increasing the likely accessibility of your paper to 
potential readers searching the literature. Therefore, ensure keywords are descriptive 
of the study. Refer to http://www.nlm.nih.gov/mesh/meshhome.html for the MeSH 
thesaurus. 
 
Abstract  
Both qualitative and quantitative research approaches should be accompanied by a 
structured abstract. Commentaries and Essays may continue to use text based 
abstracts of no more than 150 words. All original articles should include the following 
headings in the abstract as appropriate: Background, Objective, Design, Setting, 
Methods, Subjects, Results, and Conclusions. As an absolute minimum: Objectives, 
Methods, Results, and Conclusions must be provided for all original articles. 
Abstracts for reviews of the literature (in particular systematic reviews and meta-
analysis) should include the following headings as appropriate: Objectives, Data 
Sources, Study Selection, Data Extraction, Data Synthesis, Conclusions. Abstracts for 
Case Studies should include the following headings as appropriate: Background, 
Objectives, Clinical Features, Intervention and Outcomes, Conclusions. 
 
Text  
The text of observational and experimental articles is usually, but not necessarily, 
divided into sections with the headings; introduction, methods, results, results and 
discussion. In longer articles, headings should be used only to enhance the readability. 
Three categories of headings should be used: 
 
•major ones should be typed in capital letter in the centre of the page and underlined 
•secondary ones should be typed in lower case (with an initial capital letter) in the left 
hand margin and underlined 
•minor ones typed in lower case and italicised 
 
 
Do not use 'he', 'his' etc. here the sex of the person is unknown; say 'the patient' etc. 
Avoid inelegant alternatives such as 'he/she'. Avoid sexist language. 
 
Statement of Competing Interests  
When submitting a Research report you will need to consider if you, or any of your 
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co-authors, are an Editor or Editorial Board member of the International Journal of 
Osteopathic Medicine. If this is the case you will need to include a section, at the end 
of your manuscript immediately before the reference section, called "Statement of 
Competing Interests". Example statement, which may require editing, is as follows: 
{Name of author} is an Editor of the Int J Osteopath Med; {Name of author} is a 
member of the Editorial Board of the Int J Osteopath Med but was not involved in 
review or editorial decisions regarding this manuscript. 
 
References  
Responsibility for the accuracy of bibliographic citations lies entirely with the 
Authors. 
 
Citations in the text: Please ensure that every reference cited in the text is also present 
in the reference list (and vice versa). Avoid using references in the abstract. 
Unpublished results and personal communications are not recommended in the 
reference list, but may be mentioned in the text. If these references are included in the 
reference list they should follow the standard reference style of the journal and should 
include a substitution of the publication date with either "Unpublished results" or 
"Personal communication" Citation of a reference as "in press" implies that the item 
has been accepted for publication. 
 
Text: Indicate references by superscript numbers in the text. The actual Authors can 
be referred to, but the reference number(s) must always be given. 
 
List: Number the references in the list in the order in which they appear in the text. 
 
Examples:  
 
Reference to a journal publication: 
 
1. Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. J 
Sci Commun 2000;163:51-9. 
 
Reference to a book: 
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